First Internet Bancorp (INBK) 10-Q 10 May 23 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 05, 2023
Class of Stock [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35750
Entity Registrant Name	First Internet Bancorp
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	20-3489991
Entity Address, Address Line One	8701 East 116th Street
Entity Address, City or Town	Fishers
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46038
City Area Code	317
Local Phone Number	532-7900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,905,477
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Amendment Flag	false
Entity Central Index Key	0001562463
Current Fiscal Year End Date	--12-31
Common Stock
Class of Stock [Line Items]
Title of 12(b) Security	Common Stock, without par value
Trading Symbol	INBK
Security Exchange Name	NASDAQ
6.0% Fixed to Floating Subordinated Notes due 2029
Class of Stock [Line Items]
Title of 12(b) Security	6.0% Fixed to Floating Subordinated Notes due 2029
Trading Symbol	INBKZ
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and due from banks	$ 27,741	$ 17,426
Interest-bearing deposits	276,231	239,126
Total cash and cash equivalents	303,972	256,552
Total available-for-sale securities	395,833	390,384
Held-to-maturity, debt securities, after allowance for credit loss	210,761	189,168
Loans held-for-sale (includes $2,209 and $9,110 at fair value in 2023 and 2022, respectively)	18,144	21,511
Loans	3,607,242	3,499,401
Allowance for credit losses - loans	(36,879)	(31,737)
Net loans	3,570,363	3,467,664
Accrued interest receivable	22,322	21,069
Federal Home Loan Bank of Indianapolis stock	28,350	28,350
Cash surrender value of bank-owned life insurance	40,105	39,859
Premises and equipment, net	74,248	72,711
Goodwill	4,687	4,687
Servicing asset, at fair value	7,312	6,255
Other real estate owned	106	0
Accrued income and other assets	45,116	44,894
Total assets	4,721,319	4,543,104
Liabilities and Shareholders’ Equity
Noninterest-bearing deposits	140,449	175,315
Interest-bearing deposits	3,481,841	3,265,930
Total deposits	3,622,290	3,441,245
Advances from Federal Home Loan Bank	614,929	614,928
Subordinated debt, net of unamortized debt issuance costs of $2,392 and $2,468 in 2023 and 2022, respectively	104,608	104,532
Accrued interest payable	2,592	2,913
Accrued expenses and other liabilities	21,328	14,512
Total liabilities	4,365,747	4,178,130
Commitments and Contingencies
Shareholders’ Equity
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none	0	0
Retained earnings	197,623	205,675
Accumulated other comprehensive loss	(31,253)	(33,636)
Total shareholders’ equity	355,572	364,974
Total liabilities and shareholders’ equity	4,721,319	4,543,104
Voting Common Stock
Shareholders’ Equity
Common stock	189,202	192,935
Nonvoting Common Stock
Shareholders’ Equity
Common stock	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Amortized cost	$ 436,520	$ 436,183
Held-to-maturity, at fair value	192,463	168,483
Loans held-for-sale, at fair value	2,209	9,110
Unamortized discounts and debt issuance costs	$ 2,392	$ 2,468
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	4,913,779	4,913,779
Preferred stock, shares issued (in shares)	0	0
Preferred stock, share outstanding (in shares)	0	0
Voting Common Stock
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	45,000,000	45,000,000
Common stock, shares issued (in shares)	8,943,477	9,065,883
Common stock, shares outstanding (in shares)	8,943,477	9,065,883
Nonvoting Common Stock
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	86,221	86,221
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Interest Income
Loans	$ 43,843	$ 33,188
Securities – taxable	3,606	2,221
Securities – non-taxable	798	249
Other earning assets	3,786	376
Total interest income	52,033	36,034
Interest Expense
Deposits	27,270	6,097
Other borrowed funds	5,189	4,187
Total interest expense	32,459	10,284
Net Interest Income	19,574	25,750
Provision for credit losses	9,415	791
Net Interest Income After Provision for Credit Losses	10,159	24,959
Noninterest Income
Gain on sale of loans	4,061	3,845
Other	370	498
Total noninterest income	5,446	6,820
Noninterest Expense
Salaries and employee benefits	11,794	9,878
Marketing, advertising and promotion	844	756
Consulting and professional services	926	1,925
Data processing	659	449
Loan expenses	1,977	1,582
Premises and equipment	2,777	2,540
Deposit insurance premium	543	281
Other	1,434	1,369
Total noninterest expense	20,954	18,780
(Loss) Income Before Income Taxes	(5,349)	12,999
Income Tax (Benefit) Provision	(2,332)	1,790
Net (Loss) Income	$ (3,017)	$ 11,209
(Loss) Income Per Share of Common Stock
Basic (in dollars per share)	$ (0.33)	$ 1.14
Diluted (in dollars per share)	$ (0.33)	$ 1.14
Weighted-Average Number of Common Shares Outstanding
Basic (in shares)	9,024,072,000	9,790,122,000
Diluted (in shares)	9,024,072,000	9,870,394,000
Dividends Declared Per Share (in dollars per share)	$ 0.06	$ 0.06
Service charges and fees
Noninterest Income
Noninterest income	$ 209	$ 316
Loan servicing revenue
Noninterest Income
Noninterest income	785	585
Loan servicing asset revaluation
Noninterest Income
Noninterest income	(55)	(297)
Mortgage banking activities
Noninterest Income
Noninterest income	$ 76	$ 1,873

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net (loss) income	$ (3,017)	$ 11,209
Net unrealized holding gain (losses) recorded within other comprehensive income (loss) before income tax	5,112	(17,881)
Income tax provision (benefit)	1,170	(4,077)
Reclassification of securities from available-for-sale to held-to-maturity	0	(5,402)
Amortization of net unrealized holding losses on securities transferred from available-for-sale to held-to-maturity	158	119
Income tax provision (benefit)	46	(1,249)
Net effect on other comprehensive income (loss)	112	(4,034)
Net unrealized holding (losses) gains on cash flow hedging derivatives recorded within other comprehensive income before income tax	(2,170)	9,334
Income tax (benefit) provision	(499)	3,318
Net effect on other comprehensive (loss) income	(1,671)	6,016
Total other comprehensive income (loss)	2,383	(11,822)
Comprehensive loss	(634)	(613)
Available-For-Sale Securities
Net effect on other comprehensive income (loss)	$ 3,942	$ (13,804)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock Voting and Nonvoting Common Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Balance, beginning of period at Dec. 31, 2021	$ 380,338		$ 218,946	$ 172,431		$ (11,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	11,209			11,209
Other comprehensive income (loss)	(11,822)					(11,822)
Dividends declared	(597)			(597)
Recognition of the fair value of share-based compensation	640		640
Repurchased shares of common stock (161,691)	(5,118)		(5,118)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	5		5
Balance, end of period at Mar. 31, 2022	374,655		214,473	183,043		(22,861)
Balance, beginning of period at Dec. 31, 2021	$ 380,338		218,946	172,431		(11,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Balance, end of period at Dec. 31, 2022	$ 364,974	$ (4,491)	192,935	205,675	$ (4,491)	(33,636)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(3,017)			(3,017)
Other comprehensive income (loss)	2,383					2,383
Dividends declared	(544)			(544)
Recognition of the fair value of share-based compensation	372		372
Repurchased shares of common stock (161,691)	(4,002)		(4,002)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	3		3
Common stock redeemed for the net settlement of share-based awards	(106)		(106)
Balance, end of period at Mar. 31, 2023	$ 355,572		$ 189,202	$ 197,623		$ (31,253)

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.06	$ 0.06
Repurchased shares of common stock (in shares)	(161,691)	(103,703)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Activities
Net (loss) income	$ (3,017)	$ 11,209
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	1,058	2,328
Increase in cash surrender value of bank-owned life insurance	(246)	(233)
Provision for credit losses	9,415	791
Share-based compensation expense	372	640
Loans originated for sale	(91,789)	(184,067)
Proceeds from sale of loans	98,433	202,011
Gain on loans sold	(4,525)	(5,907)
Decrease in fair value of loans held-for-sale	136	489
Gain (loss) on derivatives	536	(2,565)
Loan servicing asset revaluation	55	297
Net change in accrued income and other assets	(2,444)	13,867
Net change in accrued expenses and other liabilities	(2,086)	(7,999)
Net cash provided by operating activities	5,898	30,861
Investing Activities
Net loan activity, excluding purchases	(25,111)	32,510
Proceeds from sale of other real estate owned	0	1,188
Maturities and calls of securities available-for-sale	9,448	29,008
Purchase of securities available-for-sale	(1,411)	(10,133)
Maturities and calls of securities held-to-maturity	5,129	765
Purchase of securities held-to-maturity	(26,572)	(8,320)
Redemption of Federal Home Loan Bank of Indianapolis stock	0	431
Purchase of premises and equipment	(2,704)	(9,808)
Loans purchased	(90,029)	(40,059)
Net proceeds from sale of portfolio loans	0	14,466
Other investing activities	(1,315)	374
Net cash (used in) provided by investing activities	(132,565)	10,422
Financing Activities
Net increase in deposits	178,743	39,020
Cash dividends paid	(548)	(596)
Repurchase of common stock	(4,002)	(5,118)
Proceeds from advances from Federal Home Loan Bank	110,000	110,000
Repayment of advances from Federal Home Loan Bank	(110,000)	(110,000)
Other, net	(106)	0
Net cash provided by financing activities	174,087	33,306
Net Increase in Cash and Cash Equivalents	47,420	74,589
Cash and Cash Equivalents, Beginning of Period	256,552	442,960
Cash and Cash Equivalents, End of Period	303,972	517,549
Supplemental Disclosures
Cash paid during the period for interest	32,782	10,770
Cash paid during the period for taxes	285	50
Loans transferred to other real estate owned	106	0
Loans transferred to held-for-sale from portfolio	0	14,049
Cash dividends declared, paid in subsequent period	537	581
Securities purchased during the period, settled in subsequent period	8,344	0
Transfer of available-for-sale mortgage-backed securities to held-to-maturity mortgage-backed securities at fair value	$ 0	$ 96,220

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results expected for the year ending December 31, 2023 or any other period. The March 31, 2023 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2022. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for credit losses, income taxes, valuations and impairments of investment securities and goodwill, as well as fair value measurements of derivatives and loans held-for-sale are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements. The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company. Other than the adoption of new accounting standards, the Company has not changed its significant accounting and reporting policies from those disclosed in the Company’s Form 10-K for the year ended December 31, 2022. Adoption of new accounting standards ASU 2016 - 13 On January 1, 2023, the Company adopted ASU 2016-03 Financial Instruments - Credit losses (“ASC 326”): Measurement of Credit Losses on Financial Instruments, as amended, which replaces the incurred loss methodology with an expected credit loss (“CECL”) methodology. The CECL estimate is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit exposures, including loan commitments, standby letters of credit, financial guarantees and other similar instruments. Additionally, ASC 326 resulted in changes to the accounting for available-for-sale and held-to-maturity debt securities. The Company adopted ASC 326 for all financial assets measured at amortized cost, available for sale securities and off-balance sheet credit exposures. Results for reporting periods beginning after January 1, 2023 are presented under ASC 326, while prior period amounts continue to be reported in accordance with previously applicable U.S. GAAP. The Company recorded a net decrease to retained earnings of $4.5 million as of January 1, 2023 for the cumulative effect of adopting ASC 326. The net adjustment to allowance for credit losses (“ACL”) includes $2.3 million related to loans, $1.9 million related to off-balance sheet credit exposures and $0.3 million related to held-to-maturity debt securities. ACL - Available-For-Sale (“AFS”) Debt Securities For AFS debt securities in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value through income. For AFS debt securities that do not meet the aforementioned criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors, such as interest rates or market conditions. In making this assessment, management considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded. Changes in the ACL are recorded as a provision for, or recovery of, credit loss expense. Losses are charged against the allowance when management believes that uncollectibility of an AFS debt security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Accrued interest receivable on AFS debt securities totaled $2.0 million at March 31, 2023 and is excluded from the estimate of credit losses. The Company made the policy election to exclude accrued interest from the amortized cost basis of AFS debt securities and report accrued interest separately on the condensed consolidated balance sheet. ACL - Held-To-Maturity (“HTM”) Debt Securities Management measures expected credit losses on HTM debt securities on a collective basis by major security type. Accrued interest receivable on HTM debt securities totaled $0.8 million at March 31, 2023 and is excluded from the estimate of credit losses. The Company made the accounting policy election to not measure an ACL for accrued interest. Accrued interest deemed uncollectible will be written off through interest income. The HTM securities portfolio includes municipal securities, residential mortgage-backed-securities, commercial mortgage-backed securities and corporate securities. All residential and commercial mortgage-backed securities are U.S. government issued or sponsored and substantially all municipal and corporate securities are rated investment grade or above. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. At the time of adoption, the estimated reserve was $0.3 million. ACL - Loans The ACL for loans represents management's estimate of all expected credit losses over the expected life of the Company’s existing loan portfolio. Management estimates the ACL balance using relevant available information about the collectability of cash flows, from internal and external sources, including historical information relating to past events, current conditions, and reasonable and supportable forecasts of future economic conditions. When the Company is unable to forecast future economic events, management may revert to historical information. Accrued interest receivable on loans totaled $17.7 million and is excluded from the estimate of credit losses. The Company made the accounting policy election to not measure an ACL for accrued interest receivable. Accrued interest deemed uncollectible will be written off through interest income. ACL - Loans - Collectively Evaluated The ACL is measured on a collective pool basis when similar risk characteristics exist. The Company has identified the following portfolio segments in the table below. The Company utilized a discounted cash flow (“DCF”) method to estimate the quantitative portion of the allowance for credit losses for loans evaluated on a collective pooled basis. For each segment, a loss driver analysis was performed in order to identify loss drivers and create a regression model for use in forecasting cash flows. In creating the DCF model, the Company has established a one-year reasonable and supportable forecast period with a one-year straight line reversion to the long-term historical average. Due to its minimal loss history, the Company elected to use peer data for a more reasonable calculation. Key inputs into the DCF model include loan-level detail, including the amortized cost basis of individual loans, payment structure, loss history, and forecasted loss drivers. The Company utilizes a third party to provide economic forecasts under various scenarios, which are assessed quarterly considering the scenarios in the context of the current economic environment and loss risk. Expected credit losses are estimated over the contractual term of the loans and adjusted for prepayments when appropriate. The contractual term excludes extensions, renewals, and modifications unless the extension or renewal options are included in the original or modified contract at the reporting date and are not unconditionally cancellable by the Company. Additional key assumptions in the DCF model include the probability of default (“PD”), loss given default (“LGD”), and prepayment/curtailment rates. The Company utilizes the model-driven PD and a LGD derived from a method referred to as Frye Jacobs. The Frye Jacobs method is a mathematical formula that traces the relationship between LGD and PD over time and projects the LGD based on the level of PD forecasted. In all cases, the Frye Jacobs method is utilized to calculate LGDs during the forecast period, reversion period and long-term historical average. Prepayment and curtailment rates were calculated through third party analysis of the Company’s own data. Qualitative factors for the DCF and weighted-average remaining maturity methodologies include the following: • Changes in lending policies and procedures, including changes in underwriting standards and collections, charge-offs and recovery practices • Changes in international, national, regional and local conditions • Changes in the nature and volume of the portfolio and terms of loans • Changes in the experience, depth and ability of lending management • Changes in the volume and severity of past due loans and other similar conditions • Changes in the quality of the organization’s loan review system • Changes in the value of underlying collateral for collateral dependent loans • The existence and effect of any concentrations of credit and changes in the levels of such concentrations • The effect of other external factors (i.e. competition, legal and regulatory requirements) on the level of estimated credit losses ACL - Loans - Individually Evaluated Loans that do not share risk characteristics are evaluated on an individual basis and are excluded from the collective evaluation. The Company has determined that any loans which have been placed on nonaccrual status will be individually evaluated. Individual analysis will establish a specific reserve for loans, if necessary. Specific reserves on nonaccrual loans are typically based on management’s best estimate of the fair value of collateral securing these loans, adjusted for selling costs as necessary. ACL - Off-Balance Sheet Credit Exposures The Company estimates expected credit losses over the contractual period in which the Company is exposed to credit risk via a contractual obligation to extend credit, unless that obligation is unconditionally cancellable by the Company. The allowance on off-balance sheet credit exposure is recorded as a liability and adjusted as a provision for credit loss expense. The estimate includes consideration of the likelihood that funding will occur and an estimate of expected credit losses on commitments expected to be funded over its estimated life. Funding rates are based on a historical analysis of the Company’s portfolio, while estimates of credit losses are determined using the same loss rates as funded loans. Regulatory Capital As permitted by the federal banking regulatory agencies, the Company has elected the option to delay the impact of the day one adoption of ASC 326. Refer to “Item 2. Regulatory Capital Requirements” for details of the phase-in transition adjustments. Modified Loans to Borrowers Experiencing Financial Difficulty Concurrent with the adoption of ASU 2016-03, the Company adopted ASU 2022-02 “Financial Instruments-Credit Losses (ASC 326): Troubled Debt restructurings and Vintage Disclosures,” as amended. The update eliminated the accounting guidance for troubled debt restructurings (“TDRs”) by creditors, while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Revision of Previously Issued Financial Statements The Company has revised amounts reported in previously issued financial statements for the periods presented in this Quarterly Report on Form 10-Q due to immaterial clerical errors. The clerical errors caused certain amounts related to

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share (Loss) earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period. The following is a reconciliation of the weighted-average common shares for the basic and diluted (loss) earnings per share computations for the three months ended March 31, 2023 and 2022. (dollars in thousands, except per share data) Three Months Ended March 31, 2023 2022 Basic (loss) earnings per share Net (loss) income $ (3,017) $ 11,209 Weighted-average common shares 9,024,072 9,790,122 Basic (loss) earnings per common share $ (0.33) $ 1.14 Diluted (loss) earnings per share Net (loss) income $ (3,017) $ 11,209 Weighted-average common shares 9,024,072 9,790,122 Dilutive effect of equity compensation — 80,272 Weighted-average common and incremental shares 9,024,072 9,870,394 Diluted (loss) earnings per common share 1 $ (0.33) $ 1.14 1 Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Since the Company was in a loss position for the three months ended March 31, 2023, basic net loss is the same as diluted net loss per share, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 661 for the three months ended March 31, 2022.

Securities

Securities	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Securities	Securities The following tables summarize securities available-for-sale and securities held-to-maturity as of March 31, 2023 and December 31, 2022. March 31, 2023 Amortized Gross Unrealized Fair (in thousands) Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 38,675 $ 49 $ (1,677) $ 37,047 Municipal securities 69,243 602 (1,209) 68,636 Agency mortgage-backed securities - residential 1 249,795 7 (33,050) 216,752 Agency mortgage-backed securities - commercial 16,739 — (1,209) 15,530 Private label mortgage-backed securities - residential 11,445 — (1,170) 10,275 Asset-backed securities 5,000 — (2) 4,998 Corporate securities 45,623 2 (3,030) 42,595 Total available-for-sale $ 436,520 $ 660 $ (41,347) $ 395,833 March 31, 2023 Amortized Cost Gross Unrealized Fair Value Allowance for Credit Losses Net Carrying Value (in thousands) Gains Losses Securities held-to-maturity Municipal securities $ 13,935 $ 10 $ (801) $ 13,144 $ (3) $ 13,932 Mortgage-backed securities - residential 146,809 11 (13,553) 133,267 — 146,809 Mortgage-backed securities - commercial 5,806 — (1,103) 4,703 — 5,806 Corporate securities 44,547 — (3,198) 41,349 (333) 44,214 Total held-to-maturity $ 211,097 $ 21 $ (18,655) $ 192,463 $ (336) $ 210,761 1 Includes $0.5 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of March 31, 2023. Accrued interest receivable on AFS and HTM securities at March 31, 2023 was $2.0 million and $0.8 million, respectively, and is included in accrued interest receivable on the condensed consolidated balance sheet. The Company elected to exclude all accrued interest receivable from securities when estimating credit losses. Over 97% of mortgage-backed securities (including both AFS and HTM) held by the Company are issued by U.S. government-sponsored entities and agencies. These securities are either explicitly or implicitly guaranteed by the U.S. government and have a long history of no credit losses; therefore, the Company did not record an ACL on these securities. Additionally, the Company evaluated credit impairment for individual AFS securities that are in an unrealized loss position and determined that the unrealized losses are unrelated to credit quality and are primarily attributable to changes in interest rates and volatility in the financial markets. As the Company does not intend to sell the AFS securities that are in an unrealized loss position and it is unlikely that it will be required to sell these securities before recovery of their amortized cost basis, the Company did not record an ACL on these securities. In accordance with the adoption of ASC 326, the Company also evaluated its HTM securities that are in an unrealized loss position and considered issuer bond ratings, historical loss rates for bond ratings and economic forecasts. As a result, the Company recorded in an initial ACL in retained earnings of $0.3 million on January 1, 2023. The Company reevaluated these securities at March 31, 2023 and determined no additional ACL was necessary. December 31, 2022 Amortized Gross Unrealized Fair (in thousands) Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 35,606 $ — $ (1,797) $ 33,809 Municipal securities 68,958 458 (2,140) 67,276 Agency mortgage-backed securities - residential 1 252,066 — (36,974) 215,092 Agency mortgage-backed securities - commercial 17,142 — (1,302) 15,840 Private label mortgage-backed securities - residential 11,777 — (1,322) 10,455 Asset-backed securities 5,000 — (40) 4,960 Corporate securities 45,634 35 (2,717) 42,952 Total available-for-sale $ 436,183 $ 493 $ (46,292) $ 390,384 December 31, 2022 Amortized Gross Unrealized Fair (in thousands) Cost Gains Losses Value Securities held-to-maturity Municipal securities $ 13,946 $ — $ (1,114) $ 12,832 Agency mortgage-backed securities - residential 121,853 — (15,112) 106,741 Agency mortgage-backed securities - commercial 5,818 — (1,266) 4,552 Corporate securities 47,551 — (3,193) 44,358 Total held-to-maturity $ 189,168 $ — $ (20,685) $ 168,483 1 Includes $0.5 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of December 31, 2022. The carrying value of securities at March 31, 2023 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Available-for-Sale (in thousands) Amortized Fair Within one year $ 269 $ 263 One to five years 34,401 35,141 Five to ten years 45,784 43,291 After ten years 73,087 69,583 153,541 148,278 Agency mortgage-backed securities - residential 249,795 216,752 Agency mortgage-backed securities - commercial 16,739 15,530 Private label mortgage-backed securities - residential 11,445 10,275 Asset-backed securities 5,000 4,998 Total $ 436,520 $ 395,833 Held-to-Maturity (in thousands) Amortized Fair Within one year $ 495 $ 484 One to five years 8,304 8,107 Five to ten years 44,208 40,910 After ten years 5,475 4,992 58,482 54,493 Agency mortgage-backed securities - residential 146,809 133,267 Agency mortgage-backed securities - commercial 5,806 4,703 Total $ 211,097 $ 192,463 There were no gross gains or losses resulting from the sale of available-for-sale securities during the three months ended March 31, 2023 and March 31, 2022, respectively. Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at March 31, 2023 and December 31, 2022 was $573.4 million and $527.4 million, which was approximately 97% and 94%, respectively, of the Company’s AFS and HTM securities portfolios. As of March 31, 2023, the Company’s security portfolio consisted of 459 securities, of which 431 were in an unrealized loss position. As of December 31, 2022, the Company’s security portfolio consisted of 445 securities, of which 434 were in an unrealized loss position. The unrealized losses are related to the categories noted below. U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. The Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be upon maturity. As of March 31, 2023, the unrealized losses occurred as a result of changes in interest rates, market spreads and market conditions subsequent to purchase. Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost basis over the terms of the securities. The Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be upon maturity. As of March 31, 2023, the unrealized losses occurred as a result of changes in interest rates, market spreads and market conditions subsequent to purchase. The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2023 and December 31, 2022. March 31, 2023 Less Than 12 Months 12 Months or Longer Total (in thousands) Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ 11,764 $ (413) $ 20,681 $ (1,264) $ 32,445 $ (1,677) Municipal securities 32,847 (155) 43,485 (1,054) 76,332 (1,209) Agency mortgage-backed securities- residential 29,536 (3,708) 185,093 (29,342) 214,629 (33,050) Agency mortgage-backed securities- commercial — — 15,530 (1,209) 15,530 (1,209) Private label mortgage-backed securities - residential 127 (15) 10,148 (1,155) 10,275 (1,170) Asset-backed securities — — 4,998 (2) 4,998 (2) Corporate securities 25,769 (857) 14,828 (2,173) 40,597 (3,030) Total $ 100,043 $ (5,148) $ 294,763 $ (36,199) $ 394,806 $ (41,347) December 31, 2022 Less Than 12 Months 12 Months or Longer Total (in thousands) Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ 29,668 $ (1,008) $ 4,141 $ (789) $ 33,809 $ (1,797) Municipal securities 39,557 (1,766) 4,778 (374) 44,335 (2,140) Agency mortgage-backed securities - residential 170,026 (29,690) 45,066 (7,284) 215,092 (36,974) Agency mortgage-backed securities - commercial 10,560 (926) 5,280 (376) 15,840 (1,302) Private label mortgage-backed securities 2,445 (330) 8,010 (992) 10,455 (1,322) Asset-backed securities 4,960 (40) — — 4,960 (40) Corporate securities 21,568 (1,452) 13,239 (1,265) 34,807 (2,717) Total $ 278,784 $ (35,212) $ 80,514 $ (11,080) $ 359,298 $ (46,292) December 31, 2022 Less Than 12 Months 12 Months or Longer Total (in thousands) Fair Unrealized Fair Unrealized Fair Unrealized Securities held-to-maturity Municipal securities $ 8,160 $ (661) $ 4,258 $ (453) $ 12,418 $ (1,114) Agency mortgage-backed securities - residential 68,408 (8,848) 38,332 (6,264) 106,740 (15,112) Agency mortgage-backed securities - commercial 4,552 (1,266) — — 4,552 (1,266) Corporate securities 36,866 (2,685) 7,492 (508) 44,358 (3,193) Total $ 117,986 $ (13,460) $ 50,082 $ (7,225) $ 168,068 $ (20,685) The following table summarizes ratings for the Company’s HTM portfolio issued by state and political subdivisions and other securities as of March 31, 2023. Held-to-Maturity (in thousands) State and Municipal Other Total Aaa/AAA $ 8,684 $ — $ 8,684 Aa1/AA+ 1,271 — 1,271 Aa2/AA 1,540 — 1,540 A1/A+ 1,794 — 1,794 A2/A 646 — 646 A3/A- — 9,517 9,517 Baa1/BBB+ — 9,500 9,500 Baa2/BBB — 11,000 11,000 Baa3/BBB- — 14,530 14,530 Not Rated 1 — 152,615 152,615 Total $ 13,935 $ 197,162 $ 211,097 1 HTM agency mortgage-backed securities - commercial and residential are listed under Other securities as not rated.

Loans

Loans	3 Months Ended
	Mar. 31, 2023
Receivables [Abstract]
Loans	Loans Loan balances as of March 31, 2023 and December 31, 2022 are summarized in the table below. Categories of loans include: (in thousands) March 31, 2023 December 31, 2022 Commercial loans Commercial and industrial $ 113,198 $ 126,108 Owner-occupied commercial real estate 59,643 61,836 Investor commercial real estate 142,174 93,121 Construction 158,147 181,966 Single tenant lease financing 952,533 939,240 Public finance 604,898 621,032 Healthcare finance 256,670 272,461 Small business lending 136,382 123,750 Franchise finance 382,161 299,835 Total commercial loans 2,805,806 2,719,349 Consumer loans Residential mortgage 392,062 383,948 Home equity 26,160 24,712 Other consumer loans 338,133 324,598 Total consumer loans 756,355 733,258 Total commercial and consumer loans 3,562,161 3,452,607 Net deferred loan origination fees/costs and premiums/discounts on purchased loans and other 1 45,081 46,794 Total loans 3,607,242 3,499,401 Allowance for credit losses (36,879) (31,737) Net loans $ 3,570,363 $ 3,467,664 1 Includes carrying value adjustments of $31.5 million and $32.5 million related to terminated interest rate swaps associated with public finance loans as of March 31, 2023 and December 31, 2022, respectively. Risk characteristics of each loan portfolio segment are as follows: Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States. Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States and its loans are often secured by manufacturing and service facilities, as well as office buildings. Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the Midwest and Southwest regions of the United States. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects unless other underwriting factors are present to mitigate these additional risks. Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, and multi-family) properties, land development for residential properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States. Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses. The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant. Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria. Public Finance: These loans are made on a nationwide basis to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; renewable energy projects; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment. Healthcare Finance: These loans are made on a nationwide basis to healthcare providers, primarily dentists, for practice acquisition financing or refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities and secondarily on the underlying collateral provided by the borrower. Small Business Lending: These loans are made on a nationwide basis to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration (“SBA”) under its 7(a) loan program. We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. Franchise Finance: These loans are made on a nationwide basis through our partnership with ApplePie Capital, which through their deep relationships with franchise brands provides franchisees with financing options for new franchise units, recapitalization, expansion, equipment and working capital. The sources of repayment are either based on identified cash flows from existing operations of the borrower or pro forma cash flow for new franchise locations. Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Bank typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country. Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Bank offered these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market. Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country. Allowance for Credit Losses (“ACL”) Methodology The ACL for loans represents management's estimate of all expected credit losses over the expected life of the Company’s existing loan portfolio. Management estimates the ACL balance using relevant available information about the collectability of cash flows, from internal and external sources, including historical information relating to past events, current conditions, and reasonable and supportable forecasts of future economic conditions. When the Company is unable to forecast future economic events, management may revert to historical information. The Company's methodologies incorporate a one-year reasonable and supportable forecast period with a one-year straight line reversion to the long-term historical average. The ACL methodology may also consider other adjustments to address changes in conditions, trends, and circumstances such as local industry changes that could have a significant impact on the risk profile of the loan portfolio and provide for adjustments that may not be reflected and/or captured in the historical loss data. These factors include: lending policies, imprecision in forecasting future economic conditions, loan profile, lending staff, problem loan trends, loan review, collateral, credit concentration, or other internal and external factors. The Company also includes qualitative adjustments to the allowance based on factors and considerations that have not otherwise been fully accounted for. Qualitative adjustments include, but are not limited to: • Changes in lending policies and procedures, including changes in underwriting standards and collections, charge-offs and recovery practices • Changes in international, national, regional and local conditions • Changes in the nature and volume of the portfolio and terms of loans • Changes in the experience, depth and ability of lending management • Changes in the volume and severity of past due loans and other similar conditions • Changes in the quality of the organization’s loan review system • Changes in the value of underlying collateral for collateral dependent loans • The existence and effect of any concentrations of credit and changes in the levels of such concentrations • The effect of other external factors (i.e. competition, legal and regulatory requirements) on the level of estimated credit losses The ACL is measured on a collective or pool basis when similar risk characteristics exist. The Company segments its portfolio generally by Federal Financial Institutions Examination Council ("FFIEC") Call Report codes that align with its lines of business. Additional sub-segmentation may be utilized to identify groups of loans with unique risk characteristics relative to the rest of the portfolio. Loans that do not share similar risk characteristics are evaluated on an individual basis. These evaluations are typically performed on loans with a deteriorated internal risk rating. The allowance for credit loss is determined based on several methods, including estimating the fair value of the underlying collateral or the present value of expected cash flows. The Company relies on a third-party platform that offers multiple methodologies to measure historical life-of-loan losses. Modified Loans to Borrowers Experiencing Financial Difficulty The Company may make modifications to certain loans in order to alleviate temporary difficulties in the borrower’s financial condition and/or constraints on the borrower’s ability to repay the loan, and to minimize potential losses to the Company. Modifications may include changes in the amortization terms of the loan, reductions in interest rates, acceptance of interest only payments, and/or reductions to the outstanding loan balance. Such loans are typically placed on nonaccrual status when there is doubt concerning the full repayment of principal and interest or the loan has been in default for a period of 90 days or more. These loans may be returned to accrual status when all contractual amounts past due have been brought current, and the borrower’s performance under the modified terms of the loan agreement and the ultimate collectability of all contractual amounts due under the modified terms is no longer in doubt. The Company typically measures the ACL on modified loans to borrowers experiencing financial difficulty on an individual basis when the loans are deemed to no longer share risk characteristics that are similar with other loans in the portfolio. The determination of the ACL for these loans is based on a discounted cash flow approach for both those measured collectively and individually, unless the loan is deemed collateral dependent, which requires measurement of the ACL based on the estimated expected fair value of the underlying collateral, less costs to sell. GAAP requires the Company to make certain disclosures related to these loans, including certain types of modifications, as well as how such loans have performed since their modifications. Provision for Credit Losses A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations. Policy for Charging Off Loans The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest. The following tables present changes in the balance of the ACL during the three months ended March 31, 2023. (in thousands) Three Months Ended March 31, 2023 Allowance for credit losses: Balance, Beginning of Period Adoption of CECL (Credit) Provision Charged to Expense Losses Recoveries Balance, Commercial and industrial $ 1,711 $ (120) $ 6,810 $ (6,965) $ 1 $ 1,437 Owner-occupied commercial real estate 651 62 (1) — — 712 Investor commercial real estate 1,099 (191) 368 — — 1,276 Construction 2,074 (435) (88) — — 1,551 Single tenant lease financing 10,519 (346) 100 — — 10,273 Public finance 1,753 (135) (48) — — 1,570 Healthcare finance 2,997 1,034 (336) — — 3,695 Small business lending 2,168 334 (105) (60) 3 2,340 Franchise finance 3,988 (313) 997 — — 4,672 Residential mortgage 1,559 406 594 — 2 2,561 Home equity 69 133 51 — 1 254 Other consumer loans 3,149 2,533 1,031 (232) 57 6,538 Total $ 31,737 $ 2,962 $ 9,373 $ (7,257) $ 64 $ 36,879 Prior to the adoption of ASU 2016-13 on January 1, 2023, the Company calculated the allowance for loan losses using the incurred loss methodology. The following table presents the activity in the allowance for loan losses by segment for the three months ended March 31, 2022. (in thousands) Three Months Ended March 31, 2022 Allowance for loan losses: Balance, Beginning of Period (Credit) Provision Charged to Expense Losses Recoveries Balance, Commercial and industrial $ 1,891 $ 88 $ — $ — $ 1,979 Owner-occupied commercial real estate 742 (116) — — 626 Investor commercial real estate 328 77 — — 405 Construction 1,612 154 — — 1,766 Single tenant lease financing 10,385 (1,645) — 1,231 9,971 Public finance 1,776 7 — — 1,783 Healthcare finance 5,940 (430) — — 5,510 Small business lending 1,387 111 (80) 17 1,435 Franchise finance 1,083 354 — — 1,437 Residential mortgage 643 87 — 1 731 Home equity 64 (1) — 2 65 Other consumer loans 1,990 263 (163) 99 2,189 Tax refund advance loans — 1,842 (1,488) — 354 Total $ 27,841 $ 791 $ (1,731) $ 1,350 $ 28,251 In addition to the ACL, the Company established a reserve for off-balance sheet commitments, classified in other liabilities, as required by the adoption of the CECL methodology for measuring credit losses. This reserve is maintained at a level management believes to be sufficient to absorb losses arising from unfunded loan commitments. The day one entry for off-balance sheet commitments resulted in a reserve of $2.5 million. The adequacy of the reserve for unfunded commitments is determined quarterly based on methodology similar to the methodology for determining the ACL. The following table details activity in the provision for credit losses on off-balance sheet commitments through March 31, 2023. (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption Provision for credit losses Balance, March 31, 2023 Off-balance sheet commitments Commercial loans Commercial and industrial $ — $ 110 $ 39 $ 149 Owner-occupied commercial real estate — — 8 8 Investor commercial real estate — 9 39 48 Construction — 2,193 (39) 2,154 Healthcare finance — 2 — 2 Total commercial loans — 2,314 47 2,361 Consumer loans Residential mortgage — 127 (14) 113 Home equity — 52 10 62 Other consumer — 11 (1) 10 Total consumer loans — 190 (5) 185 Total allowance for off-balance sheet commitments $ — $ 2,504 $ 42 $ 2,546 The following table present the recorded investment in loans based on portfolio segment and impairment method as of December 31, 2022. (in thousands) Loans Allowance for Loan Losses December 31, 2022 Ending Balance: Ending Balance: Ending Balance Ending Balance: Ending Balance: Ending Balance Commercial and industrial $ 116,307 $ 9,801 $ 126,108 $ 1,660 $ 51 $ 1,711 Owner-occupied commercial real estate 60,266 1,570 61,836 651 — 651 Investor commercial real estate 93,121 — 93,121 1,099 — 1,099 Construction 181,966 — 181,966 2,074 — 2,074 Single tenant lease financing 939,240 — 939,240 10,519 — 10,519 Public finance 621,032 — 621,032 1,753 — 1,753 Healthcare finance 272,461 — 272,461 2,997 — 2,997 Small business lending 1 113,699 10,051 123,750 1,465 703 2,168 Franchise finance 299,835 — 299,835 3,988 — 3,988 Residential mortgage 380,272 3,676 383,948 1,559 — 1,559 Home equity 24,683 29 24,712 69 — 69 Other consumer 324,581 17 324,598 3,149 — 3,149 Total $ 3,427,463 $ 25,144 $ 3,452,607 $ 30,983 $ 754 $ 31,737 1 Balance is partially guaranteed by the U.S. government. The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows: • “Pass” - Higher quality loans that do not fit any of the other categories described below. • “Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention. • “Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. • “Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable. • “Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted. The Company does not risk grade its consumer loans. It classifies them as either performing or nonperforming. Below is a description of those classifications: • “Performing” - Loans that are accruing and full collection of principal and interest is expected. • “Nonperforming” - Loans that are 90 days delinquent or for which the full collection of principal and interest may be in doubt. The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios by loan class and by year of origination for the years indicated based on rating category and payment activity as of March 31, 2023 and December 31, 2022. March 31, 2023 Term Loans (amortized cost basis by origination year) Revolving loans amortized cost basis Revolving loans converted to term (in thousands) 2023 2022 2021 2020 2019 Prior Total Commercial and industrial Pass $ 2,393 $ 33,609 $ 15,988 $ 2,648 $ 12,826 $ 12,471 $ 29,091 $ — $ 109,026 Special Mention — 36 918 — — — 382 — 1,336 Substandard — — 2,836 — — — — — 2,836 Doubtful — — — — — — — — — Total Commercial and 2,393 33,645 19,742 2,648 12,826 12,471 29,473 — 113,198 Gross charge-offs — — 6,914 — 51 — — — 6,965 Owner-occupied commercial real estate Pass 411 11,447 9,251 6,748 6,132 14,753 — — 48,742 Special Mention — — — 8,568 — 892 — — 9,460 Substandard — — — — — 1,441 — — 1,441 Doubtful — — — — — — — — — Total owner-occupied 411 11,447 9,251 15,316 6,132 17,086 — — 59,643 Investor commercial real estate Pass 4,878 40,758 23,893 10,049 48,544 6,169 — — 134,291 Special Mention — — — — — 7,883 — — 7,883 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total investor commercial real 4,878 40,758 23,893 10,049 48,544 14,052 — — 142,174 Construction Pass 785 80,984 34,384 38,905 — 640 973 — 156,671 Special Mention — — 1,476 — — — — — 1,476 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total construction 785 80,984 35,860 38,905 — 640 973 — 158,147 Single tenant lease financing Pass 25,137 230,780 98,253 71,375 147,335 376,515 — — 949,395 Special Mention — — — — — 3,138 — — 3,138 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total single tenant lease 25,137 230,780 98,253 71,375 147,335 379,653 — — 952,533 Public finance Pass 861 79,566 31,950 7,722 48,759 433,760 — — 602,618 Special Mention — — — — — 2,280 — — 2,280 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total public finance 861 79,566 31,950 7,722 48,759 436,040 — — 604,898 March 31, 2023 Term Loans (amortized cost basis by origination year) Revolving loans amortized cost basis Revolving loans converted to term (in thousands) 2023 2022 2021 2020 2019 Prior Total Healthcare finance Pass — — 11,609 143,651 72,756 27,327 — — 255,343 Special Mention — — — — 1,327 — — — 1,327 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total healthcare finance — — 11,609 143,651 74,083 27,327 — — 256,670 Small business lending 1 Pass 19,718 49,970 17,396 16,991 5,369 14,320 2,470 — 126,234 Special Mention — 343 123 1,717 714 2,078 150 — 5,125 Substandard — 780 716 1,445 800 1,185 97 — 5,023 Doubtful — — — — — — — — — Total small business lending 19,718 51,093 18,235 20,153 6,883 17,583 2,717 — 136,382 Gross charge-offs — — — 60 — — — — 60 Franchise finance Pass 78,796 237,658 65,129 — — — — — 381,583 Special Mention — — 578 — — — — — 578 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total franchise finance 78,796 237,658 65,707 — — — — — 382,161 Consumer loans Residential mortgage Payment performance Performing 4,207 191,584 98,095 34,312 12,303 50,555 — — 391,056 Nonperforming — 235 — 76 — 695 — — 1,006 Total residential mortgage 4,207 191,819 98,095 34,388 12,303 51,250 — — 392,062 Home equity Payment performance Performing 2,463 10,080 3,903 3,518 780 3,709 1,707 — 26,160 Nonperforming — — — — — — — — — Total home equity 2,463 10,080 3,903 3,518 780 3,709 1,707 — 26,160 Other consumer Payment performance Performing 29,138 120,846 49,726 31,542 32,736 73,230 774 — 337,992 Nonperforming — 54 — — 54 33 — — 141 Total other consumer 29,138 120,900 49,726 31,542 32,790 73,263 774 — 338,133 Gross charge-offs — 35 7 8 107 75 — — 232 Total Loans $ 168,787 $ 1,088,730 $ 466,224 $ 379,267 $ 390,435 $ 1,033,074 $ 35,644 $ — $ 3,562,161 Total gross charge-offs $ — $ 35 $ 6,921 $ 68 $ 158 $ 75 $ — $ — $ 7,257 1 Balance in “Substandard” is partially guaranteed by the U.S. government. The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of December 31, 2022. December 31, 2022 (in thousands) Pass Special Mention Substandard Total Commercial and industrial $ 114,934 1,373 $ 9,801 $ 126,108 Owner-occupied commercial real estate 50,721 9,546 1,569 61,836 Investor commercial real estate 93,121 — — 93,121 Construction 180,768 1,198 — 181,966 Single tenant lease financing 936,207 3,033 — 939,240 Public finance 618,752 2,280 — 621,032 Healthcare finance 271,085 1,376 — 272,461 Small business lending 1 107,885 5,814 $ 10,051 123,750 Franchise finance 299,241 594 $ — 299,835 Wealth advisory lending — — — — Total loans $ 2,672,714 $ 25,214 $ 21,421 $ 2,719,349 1 Balance in “Substandard” is partially guaranteed by the U.S. government. December 31, 2022 (in thousands) Performing Nonaccrual Total Residential mortgage $ 382,900 $ 1,048 $ 383,948 Home equity 24,712 — 24,712 Other consumer 324,581 17 324,598 Total consumer loans $ 732,193 $ 1,065 $ 733,258 The following tables present the Company’s loan portfolio delinquency analysis as of March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) 30-59 60-89 90 Days Total Current Total Commercial and industrial $ — $ — $ — $ — $ 113,198 $ 113,198 Owner-occupied commercial real estate — — — — 59,643 59,643 Investor commercial real estate — — — — 142,174 142,174 Construction — — — — 158,147 158,147 Single tenant lease financing — — — — 952,533 952,533 Public finance — — — — 604,898 604,898 Healthcare finance — — — — 256,670 256,670 Small business lending 1 55 1,426 2,354 3,835 132,547 136,382 Franchise finance — — — — 382,161 382,161 Residential mortgage 301 234 235 770 391,292 392,062 Home equity — — — — 26,160 26,160 Other consumer 78 38 35 151 337,982 338,133 Total $ 434 $ 1,698 $ 2,624 $ 4,756 $ 3,557,405 $ 3,562,161 1 Balance is partially guaranteed by the U.S. government. December 31, 2022 (in thousands) 30-59 60-89 90 Days Total Current Total Commercial and industrial $ 81 $ — $ 51 $ 132 $ 125,976 $ 126,108 Owner-occupied commercial real estate — — — — 61,836 61,836 Investor commercial real estate — — — — 93,121 93,121 Construction — 1,198 — 1,198 180,768 181,966 Single tenant lease financing — — — — 939,240 939,240 Public finance — — — — 621,032 621,032 Healthcare finance — — — — 272,461 272,461 Small business lending 1 57 — 3,485 3,542 120,208 123,750 Franchise Finance 313 — — 313 299,522 299,835 Residential mortgage — 283 185 468 383,480 383,948 Home equity — — — — 24,712 24,712 Other consumer 91 10 — 101 324,497 324,598 Total $ 542 $ 1,491 $ 3,721 $ 5,754 $ 3,446,853 $ 3,452,607 1 Balance is partially guaranteed by the U.S. government. Loans are reclassified to a non-accruing status when, in management’s judgment, the collateral value and financial condition of the borrower do not justify accruing interest. At the time the accrual is discontinued, all unpaid accrued interest is reversed against earnings. Interest income accrued in prior years, if any, is charged to the allowance for credit losses. Payments subsequently received on nonaccrual loans are applied to principal. A loan is returned to accrual status when principal and interest are no longer past due and collectability is probable, typically after a minimum of six consecutive months of performance. The following table summarizes the Company’s nonaccrual loans and loans past due 90 days or more and still accruing by loan class for the periods indicated: March 31, 2023 December 31, 2022 (in thousands) Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Losses Total Loans Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Losses Total Loans Commercial and industrial $ 2,836 $ 2,836 $ — $ 51 $ — $ — Owner-occupied commercial real estate 1,441 1,441 — 1,570 1,570 — Small business lending 1 3,797 2,354 — 4,764 2,766 — Residential mortgage 1,006 1,006 — 1,048 1,048 79 Other consumer 141 141 — 17 17 — Total loans $ 9,221 $ 7,778 $ — $ 7,450 $ 5,401 $ — 1 Balance is partially guaranteed by the U.S. government. There was no interest income recognized on nonaccrual loans for the three months ended March 31, 2023 and $25 thousand in interest income recognized on nonaccrual loans for the three months ended March 31, 2022. Determining fair value for collateral dependent loans requires obtaining a current independent appraisal of the collateral and applying a discount factor, which includes selling costs if applicable, to the value. The fair value of real estate is generally based on appraisals by qualified licensed appraisers. The appraisers typically determine the value of the real estate by utilizing an income or market valuation approach. If an appraisal is not available, the fair value may be determined by using a cash flow analysis. Fair value on other collateral such as business assets is typically ascertained by assessing, either singularly or some combination of, asset appraisals, accounts receivable aging reports, inventory listings and or customer financial statements. Both appraised values and values based on borrower’s financial information are discounted as considered appropriate based on age and quality of the information and current market conditions. The following table presents the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses as of March 31, 2023, March 31, 2023 (in thousands) Commercial Real Estate Residential Real Estate Other Total Allowance on Collateral Dependent Loans Commercial and industrial $ — $ — $ 2,836 $ 2,836 $ — Owner-occupied commercial real estate — — 1,441 1,441 — Small business lending 1 2,147 395 877 3,419 603 Residential mortgage — 1,006 — 1,006 — Other consumer loans — — 141 141 — Total loans $ 2,147 $ 1,401 $ 5,295 $ 8,843 $ 603 1 Balance is partially guaranteed by the U.S. government. The following table presents the Company’s impaired loans as of December 31, 2022. December 31, 2022 (in thousands) Recorded Unpaid Specific Loans without a specific valuation allowance Commercial and industrial $ 9,750 $ 9,750 $ — Owner-occupied commercial real estate 1,570 1,779 — Small business lending 8,184 8,705 — Residential mortgage 3,676 3

Premises and Equipment

Premises and Equipment	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Premises and Equipment	Premises and Equipment The following table summarizes premises and equipment at March 31, 2023 and December 31, 2022. (in thousands) March 31, December 31, Land $ 5,598 $ 5,598 Construction in process 177 714 Right of use leased asset 160 206 Building and improvements 60,199 57,505 Furniture and equipment 19,995 19,585 Less: accumulated depreciation (11,881) (10,897) Total $ 74,248 $ 72,711

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill As of March 31, 2023 and December 31, 2022, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three months ended March 31, 2023 or March 31, 2022. Goodwill is assessed for impairment annually as of August 31, or more frequently if events occur or circumstances change that indicate an impairment may exist. When assessing goodwill for impairment, first, a qualitative assessment can be made to determine whether it is more likely than not that the estimated fair value of a reporting unit is less than its estimated carrying value. If the results of the qualitative assessment are not conclusive, a quantitative goodwill test is performed. Alternatively, a quantitative goodwill test can be performed without performing a qualitative assessment. Goodwill was assessed for impairment using a qualitative test performed as of August 31, 2022.

Servicing Asset

Servicing Asset	3 Months Ended
	Mar. 31, 2023
Transfers and Servicing [Abstract]
Servicing Asset	Servicing Asset Activity for the servicing asset and the related changes in fair value for the three months ended March 2023 and 2022 are shown in the table below. Three Months Ended (in thousands) March 31, 2023 March 31, 2022 Balance, beginning of period $ 6,255 $ 4,702 Additions: Originated and purchased servicing 1,112 844 Subtractions Paydowns: (339) (256) Changes in fair value due to changes in valuation inputs or assumptions used in 284 (41) Loan servicing asset revaluation $ (55) $ (297) Balance, end of period $ 7,312 $ 5,249 Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of March 31, 2023 and December 31, 2022 are shown in the table below. (in thousands) March 31, 2023 December 31, 2022 Loan portfolios serviced for: SBA guaranteed loans $ 356,808 $ 318,194 Total $ 356,808 $ 318,194 Loan servicing revenue totaled $0.8 million and $0.6 million for the three months ended March 31, 2023 and March 31, 2022, respectively. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $0.1 million and $0.3 million downward valuation for the three months ended March 31, 2023 and March 31, 2022, respectively. The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 11 - Fair Value of Financial Instruments for further details.

Subordinated Debt

Subordinated Debt	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Subordinated Debt	Subordinated Debt In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate) plus 4.11%. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. In October 2020, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2030 (the “2030 Note”). The 2030 Note initially bears a fixed interest rate of 6.0% per year to, but excluding, November 1, 2025 and thereafter at a floating rate equal to the then-current benchmark rate (initially the then current three-month term SOFR plus 5.795%). The 2030 Note is scheduled to mature on November 1, 2030. The 2030 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after November 1, 2025. The 2030 Note is intended to qualify as Tier 2 capital under regulatory guidelines. The Company used the net proceeds from the issuance of the 2030 Note to redeem a subordinated term note that had been entered into in October 2015. In August 2021, the Company issued $60.0 million aggregate principal amount of 3.75% Fixed-to-Floating Rate Subordinated Notes due 2031 (the “2031 Notes”) in a private placement. The 2031 Notes initially bear a fixed interest rate of 3.75% per year to, but excluding, September 1, 2026, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR plus 3.11%). The 2031 Notes are scheduled to mature on September 1, 2031. The 2031 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 1, 2026. The 2031 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The Company used a portion of the net proceeds from the issuance of the 2031 Notes to redeem subordinated notes issued by the Company in 2016. Pursuant to the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2031 Notes, the Company offered to exchange the 2031 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2031 Notes. On December 30, 2021, we completed an exchange of $59.3 million principal amount of the unregistered 2031 Notes for registered 2031 Notes in satisfaction of our obligations under the registration rights agreement. Holders of $0.7 million of unregistered 2031 Notes did not participate in the exchange. The following table presents the principal balance and unamortized debt issuance costs for the 2029 Notes, the 2030 Note, and the 2031 Notes as of March 31, 2023 and December 31, 2022. March 31, 2023 December 31, 2022 (in thousands) Principal Unamortized Debt Issuance Costs Principal Unamortized Debt Issuance Costs 2029 Notes $ 37,000 $ (981) $ 37,000 $ (1,020) 2030 Notes 10,000 (178) 10,000 (184) 2031 Notes 60,000 (1,233) 60,000 (1,264) Total $ 107,000 $ (2,392) $ 107,000 $ (2,468)

Benefit Plans

Benefit Plans	3 Months Ended
	Mar. 31, 2023
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans Employment Agreements The Company is party to certain employment agreements with each of its Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer. The employment agreements each provide for annual base salaries and annual bonuses, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonuses are to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee. The agreements also provide that each of the Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer, may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine. The agreements also provide for the continuation of salary and certain other benefits for a specified period of time upon termination of employment under certain circumstances, including resignation for “good reason,” termination by the Company without “cause” at any time or any termination of employment within twelve months following a “change in control,” along with other specific conditions. 2022 Equity Incentive Plan The First Internet Bancorp 2022 Equity Incentive Plan (the “2022 Plan”) was approved by our Board of Directors and ratified by our shareholders on May 16, 2022. The 2022 Plan permits awards of incentive and non-statutory stock options, stock appreciation rights, restricted stock awards, stock unit awards, performance awards and other stock-based awards. All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2022 Plan. The 2022 Plan initially authorized the issuance of 400,000 new shares of the Company’s common stock plus all shares of common stock that remained available for future grants under the First Internet Bancorp 2013 Equity Incentive Plan (the “2013 Plan”). Award Activity Under 2022 Plan The Company recorded less than $0.1 million o f share-based compensation expense for the three months ended March 31, 2023, related to stock-based awards under the 2022 Plan . The following table summarizes the stock-based award activity under the 2022 Plan for the three months ended March 31, 2023. Restricted Stock Units Weighted-Average Grant Date Fair Value Per Share Restricted Stock Awards Weighted-Average Grant Date Fair Value Per Share Deferred Stock Units Weighted-Average Grant Date Fair Value Per Share Unvested at December 31, 2022 — $ — 3,558 $ 36.84 — $ — Granted 71,660 24.75 — — — — Unvested at March 31, 2023 71,660 $ 24.75 3,558 $ 36.84 — $ — At March 31, 2023, the total unrecognized compensation cost related to unvested stock-based awards under the 2022 Plan was $1.7 million with a weighted-average expense recognition period of 2.8 years. 2013 Equity Incentive Plan The 2013 Plan authorized the issuance of 750,000 shares of the Company’s common stock in the form of stock-based awards to employees, directors, and other eligible persons. Although outstanding stock-based awards under the 2013 Plan remain in place according to their terms, our authority to grant new awards under the 2013 Plan terminated upon shareholder approval of the 2022 Plan. Award Activity Under 2013 Plan The Company recorded $0.4 million of share-based compensation expense for the three months ended March 31, 2023, related to stock-based awards under the 2013 Plan . The Company recorded $0.6 million of share-based compensation expense for the three months ended March 31, 2022, related to stock-based awards under the 2013 Plan. The following table summarizes the stock-based award activity under the 2013 Plan for the three months ended March 31, 2023. Restricted Stock Units Weighted-Average Grant Date Fair Value Per Share Restricted Stock Awards Weighted-Average Grant Date Fair Value Per Share Deferred Stock Units Weighted-Average Grant Date Fair Value Per Share Unvested at December 31, 2022 101,734 $ 35.93 — $ — — $ — Granted — — — — — — Cancelled/Forfeited (278) 27.56 — — — — Vested (35,808) 31.87 — — — — Unvested at March 31, 2023 65,648 $ 38.18 — $ — — $ — At March 31, 2023, the total unrecognized compensation cost related to unvested stock-based awards under the 2013 Plan was $1.2 million with a weighted-average expense recognition period of 1.6 years. Directors Deferred Stock Plan Until January 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right. The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the three months ended March 31, 2023. Deferred Stock Rights Outstanding, beginning of period 40,414 Granted 100 Outstanding, end of period 40,514

Commitments and Credit Risk

Commitments and Credit Risk	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Credit Risk	Commitments and Credit Risk In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying condensed consolidated financial statements. At March 31, 2023 and December 31, 2022, the Company had outstanding loan commitments totaling approximately $501.7 million and $485.4 million, respectively. Capital Commitments Capital expenditures were made in connection with the construction of the building where our corporate headquarters is located, along with an attached parking garage. The Company entered into construction-related contracts. As of March 31, 2023, the project was completed at a total cost of $67.2 million. There are no remaining capital commitments left at March 31, 2023.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurement , defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy. Available-for-Sale Securities Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage and asset-backed securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of March 31, 2023 or December 31, 2022. Loans Held-for-Sale (mandatory pricing agreements) The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2). Servicing Asset Fair value is based on a loan-by-loan basis taking into consideration the origination to maturity dates of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing asset begins with generating estimated future cash flows for each servicing asset based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3). Interest Rate Swap Agreements The fair values of interest rate swap agreements are estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data (Level 2). Forward Contracts The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1). Interest Rate Lock Commitments The fair values of IRLCs are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3). The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 37,047 $ — $ 37,047 $ — Municipal securities 68,636 — 68,636 — Agency mortgage-backed securities - residential 216,752 — 216,752 — Agency mortgage-backed securities - commercial 15,530 — 15,530 — Private label mortgage-backed securities - residential 10,275 — 10,275 — Asset-backed securities 4,998 — 4,998 — Corporate securities 42,595 — 42,595 — Total available-for-sale securities $ 395,833 $ — $ 395,833 $ — Loans held-for-sale (mandatory pricing agreements) 2,209 — 2,209 — Servicing asset 7,312 — — 7,312 Interest rate swap assets 6,089 — 6,089 — Forward contracts (22) (22) — — IRLCs — — — — December 31, 2022 (in thousands) Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 33,809 $ — $ 33,809 $ — Municipal securities 67,276 — 67,276 — Agency mortgage-backed securities - residential 215,092 — 215,092 — Agency mortgage-backed securities - commercial 15,840 — 15,840 — Private label mortgage-backed securities - residential 10,455 — 10,455 — Asset-backed securities 4,960 — 4,960 — Corporate securities 42,952 — 42,952 — Total available-for-sale securities $ 390,384 $ — $ 390,384 $ — Loans held-for-sale (mandatory pricing agreements) 9,110 — 9,110 — Servicing asset 6,255 — — 6,255 Interest rate swap agreements 8,645 — 8,645 — Forward contracts 97 97 — — IRLCs 133 — — 133 The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three months ended March 31, 2023 and 2022. Three Months Ended (in thousands) Servicing Asset Interest Rate Lock Balance, January 1, 2023 $ 6,255 $ 133 Total realized gains Additions: Originated and purchased servicing 1,112 — Subtractions: Paydowns (339) — Change in fair value 284 (133) Balance, March 31, 2023 $ 7,312 $ — Balance as of January 1, 2022 $ 4,702 $ 718 Total realized gains Additions: Originated and purchased servicing 844 — Subtractions: Paydowns (256) — Change in fair value (41) (806) Balance, March 31, 2022 $ 5,249 $ (88) The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy. Collateral Dependent Loans Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price. If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment. Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets. The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) Fair Value Measurements Using Fair Quoted Prices Significant Significant Collateral dependent loans $ 3,676 $ — $ — $ 3,676 December 31, 2022 (in thousands) Fair Value Measurements Using Fair Quoted Prices Significant Significant Impaired loans $ 1,164 $ — $ — $ 1,164 Significant Unobservable (Level 3) Inputs The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements. (dollars in thousands) Fair Value at Valuation Significant Unobservable Range Weighted-Average Range Collateral dependent loans $ 3,676 Fair value of collateral Discount for type of property and current market conditions 4% - 25% 12% Servicing asset 7,312 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 14% 11.5% 14% (dollars in thousands) Fair Value at Valuation Significant Unobservable Range Weighted-Average Range Impaired loans $ 1,164 Fair value of collateral Discount for type of property and current market conditions 0% - 25% 20% IRLCs 133 Discounted cash flow Loan closing rates 31% - 100% 89% Servicing asset 6,255 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 14% 14.6% 14% The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value. Cash and Cash Equivalents For these instruments, the carrying amount is a reasonable estimate of fair value. Securities Held-to-Maturity Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. Level 2 securities include agency mortgage-backed securities - residential, municipal securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of March 31, 2023 or December 31, 2022. Loans Held-for-Sale (best efforts pricing agreements) The fair value of these loans approximates carrying value. Loans The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors. Accrued Interest Receivable The fair value of these financial instruments approximates carrying value. Federal Home Loan Bank of Indianapolis Stock The fair value of this financial instrument approximates carrying value. Deposits The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities. Advances from Federal Home Loan Bank The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value. Subordinated Debt The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments. Accrued Interest Payable The fair value of these financial instruments approximates carrying value. Commitments The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of March 31, 2023 and December 31, 2022. The following tables present the carrying value and estimated fair value of all financial assets and liabilities that are not measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 303,972 $ 303,972 $ 303,972 $ — $ — Securities held-to-maturity, net 210,761 192,463 — 192,463 — Loans held-for-sale (best efforts pricing agreements) 15,935 15,935 — 15,935 — Net loans 3,570,363 3,378,228 — — 3,378,228 Accrued interest receivable 22,322 22,322 22,322 — — Federal Home Loan Bank of Indianapolis stock 28,350 28,350 — 28,350 — Deposits 3,622,290 3,589,180 1,778,865 — 1,810,315 Advances from Federal Home Loan Bank 614,929 601,563 — 601,563 — Subordinated debt 104,608 101,550 31,450 70,100 — Accrued interest payable 2,592 2,592 2,592 — — December 31, 2022 (in thousands) Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 256,552 $ 256,552 $ 256,552 $ — $ — Securities held-to-maturity 189,168 168,483 — 168,483 — Loans held-for-sale (best efforts pricing agreements) 12,401 12,401 — 12,401 — Net loans 3,467,664 3,225,845 — — 3,225,845 Accrued interest receivable 21,069 21,069 21,069 — — Federal Home Loan Bank of Indianapolis stock 28,350 28,350 — 28,350 — Deposits 3,441,245 3,415,390 1,974,344 — 1,441,046 Advances from Federal Home Loan Bank 614,928 596,455 — 596,455 — Subordinated debt 104,532 102,669 32,560 70,109 — Accrued interest payable 2,913 2,913 2,913 — —

Mortgage Banking Activities

Mortgage Banking Activities	3 Months Ended
	Mar. 31, 2023
Mortgage Banking [Abstract]
Mortgage Banking Activities	Mortgage Banking Activities The Bank’s residential real estate lending business originated mortgage loans for customers and typically sold a majority of the originated loans into the secondary market. For most of the mortgages sold in the secondary market, the Bank hedged its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that would be sold into the secondary market. To facilitate the hedging of the loans, the Bank elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income. Refer to Note 13 for further information on derivative financial instruments. During the three months ended March 31, 2023 and 2022, the Company originated mortgage loans held-for-sale of $36.3 million and $152.4 million, respectively, and sold $43.5 million and $162.4 million of mortgage loans, respectively, into the secondary market. The following table presents the components of income from mortgage banking activities for the three months ended March 31, 2023 and 2022. Three Months Ended March 31, (in thousands) 2023 2022 Gain on loans sold $ 464 $ 2,062 Loss resulting from the change in fair value of loans held-for-sale (136) (489) (Loss) gain resulting from the change in fair value of derivatives (252) 300 Net revenue from mortgage banking activities $ 76 $ 1,873 Fluctuations in interest rates and changes in IRLC and loan volume within the mortgage banking pipeline may cause volatility in the fair value of loans held-for-sale and the fair value of derivatives used to hedge the mortgage banking pipeline.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company entered into forward contracts for the future delivery of mortgage loans to third-party investors and entered into IRLCs with potential borrowers to fund specific mortgage loans that were sold into the secondary market. The forward contracts were entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans. The Company had various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets. The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets. The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of March 31, 2023 and December 31, 2022. (in thousands) Carrying amount of the hedged asset Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets Line item in the condensed consolidated balance sheets in which the hedged item is included March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Securities available-for-sale 1 $ 69,243 $ 68,963 $ (1,707) $ (2,088) 1 These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The designated hedged items were $50.0 million at both March 31, 2023 and December 31, 2022. The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at March 31, 2023 and December 31, 2022, identified by the underlying interest rate-sensitive instruments. (dollars in thousands) March 31, 2023 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Instruments Associated With Fair Value Receive Pay Securities available-for-sale $ 50,000 1.6 $ 1,707 3-month LIBOR 2.33 % Total at March 31, 2023 $ 50,000 1.6 $ 1,707 3-month LIBOR 2.33 % (dollars in thousands) December 31, 2022 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Instruments Associated With Fair Value Receive Pay Securities available-for-sale $ 50,000 1.8 $ 2,093 3-month LIBOR 2.33 % Total swap portfolio at December 31, 2022 $ 50,000 1.8 $ 2,093 3-month LIBOR 2.33 % In March 2021, the Company terminated the last layer of interest rate swaps associated with available-for-sale agency mortgage-backed securities - residential, which resulted in swap termination payments to counterparties totaling $1.9 million. The corresponding fair value hedging adjustment was allocated pro-rata to the underlying hedged securities and is being amortized over the remaining lives of the designated securities. Amortization expense totaling less than $0.1 million was recognized as a reduction to interest income on securities for the three months ended March 31, 2023 and 2022, respectively. In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans, which have a weighted average term to maturity of 11.1 years as of March 31, 2023. Amortization expense totaling $1.0 million and $1.0 million for the three months ended March 31, 2023 and 2022, respectively, related to these previously terminated fair value hedges was recognized as a reduction to interest income on loans. The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at March 31, 2023 and December 31, 2022. (dollars in thousands) March 31, 2023 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Cash Flow Hedges Fair Value Receive Pay Interest rate swaps $ 110,000 3.8 $ 3,126 3-month LIBOR 2.88 % Interest rate swaps 60,000 0.4 473 1-month LIBOR 2.88 % Interest rate swaps 40,000 1.2 783 Fed Funds Effective 2.78 % (dollars in thousands) December 31, 2022 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Cash Flow Hedges Fair Value Receive Pay Interest rate swaps $ 110,000 4.1 $ 4,787 3-month LIBOR 2.88 % Interest rate swaps 60,000 0.6 735 1-month LIBOR 2.88 % Interest rate swaps 40,000 1.4 1,030 Fed Funds Effective 2.78 % These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. The Company received $6.6 million and $7.7 million of cash collateral from counterparties as security for their obligations related to these swap transactions at March 31, 2023 and December 31, 2022. The Company had no pledged cash collateral as of March 31, 2023 and December 31, 2022 to counterparties on interest rate swap agreements as security for its obligations related to these agreements. Collateral posted and received is dependent on the market valuation of the underlying hedges. The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at March 31, 2023 and December 31, 2022. March 31, 2023 December 31, 2022 (in thousands) Notional Fair Notional Fair Asset Derivatives Derivatives designated as hedging instruments Interest rate swaps associated with securities available-for-sale $ 50,000 $ 1,707 $ 50,000 $ 2,093 Interest rate swaps associated with liabilities 210,000 4,382 210,000 6,552 Derivatives not designated as hedging instruments IRLCs — — 14,862 133 Forward contracts — — 17,000 97 Total contracts $ 260,000 $ 6,089 $ 291,862 $ 8,875 Liability Derivatives Derivatives not designated as hedging instruments Forward contracts $ 1,750 $ (22) $ — $ — Total contracts $ 1,750 $ (22) $ — $ — The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date. The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three months ended March 31, 2023 and 2022. Amount of Gain /(Loss) Recognized in Other Comprehensive Income (Loss) in The Three Months Ended (in thousands) March 31, 2023 March 31, 2022 Interest rate swap agreements $ (2,170) $ 9,334 The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three months ended March 31, 2023 and 2022. Amount of Gain / (Loss) Recognized in the Three Months Ended (in thousands) March 31, 2023 March 31, 2022 Asset Derivatives Derivatives not designated as hedging instruments IRLCs $ — $ — Forward contracts — 1,102 Liability Derivatives Derivatives not designated as hedging instruments IRLCs $ (133) $ (802) Forward contracts (119) — The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of operations during the three months ended March 31, 2023 and 2022. (in thousands) Line item in the condensed consolidated statements of operations Three Months Ended March 31, 2023 March 31, 2022 Interest income Securities - taxable $ — $ — Securities - non-taxable 294 (260) Total interest income 294 (260) Interest expense Deposits (418) 670 Other borrowed funds (522) 696 Total interest expense (940) 1,366 Net interest income $ 1,234 $ (1,626)

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss, included in shareholders' equity, for the three months ended March 31, 2023 and 2022, respectively, are presented in the table below. (in thousands) Unrealized Losses On Debt Securities Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity Cash Flow Hedges Total Balance, January 1, 2023 $ (35,831) $ (3,519) $ 5,714 $ (33,636) Other comprehensive income (loss) before reclassifications from accumulated other comprehensive loss before tax 5,112 — (2,170) 2,942 Reclassifications from accumulated other comprehensive loss to earnings before tax — 158 — 158 Other comprehensive gain (loss) before tax 5,112 158 (2,170) 3,100 Income tax provision (benefit) 1,170 46 (499) 717 Other comprehensive income (loss) - net of tax 3,942 112 (1,671) 2,383 Balance, March 31, 2023 $ (31,889) $ (3,407) $ 4,043 $ (31,253) Balance, January 1, 2022 $ (2,555) $ — $ (8,484) $ (11,039) Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax (17,881) (5,402) 9,334 (13,949) Reclassifications from accumulated other comprehensive loss to earnings before tax — 119 — 119 Other comprehensive (loss) gain before tax (17,881) (5,283) 9,334 (13,830) Income tax (benefit) provision (4,077) (1,249) 3,318 (2,008) Other comprehensive (loss) income - net of tax (13,804) (4,034) 6,016 (11,822) Balance, March 31, 2022 $ (16,359) $ (4,034) $ (2,468) $ (22,861) Details About Accumulated Other Comprehensive Loss Components Amounts Reclassified from Affected Line Item in the Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Reclassifications from accumulated other comprehensive loss to earnings before tax $ (158) (119) Interest income Total amount reclassified before tax (158) (119) (Loss) income before income taxes Tax benefit (46) (27) Income tax (benefit) provision Total reclassifications from accumulated other comprehensive loss $ (112) $ (92) Net (loss) income

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. • Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. • Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. • In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief . This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. The Company formed a current expected credit losses (“CECL”) working group that discussed implementation matters related to the completeness and accuracy of historical data, model development and corporate governance documentation. The new allowance model estimates credit losses over the expected life of the portfolio and includes a qualitative framework to account for drivers of losses that the quantitative model does not capture. The CECL working group discussed results from parallel model runs for each portfolio segment, assumptions related to unfunded commitments and economic forecast factors. Model validation was completed by an independent third party in the fourth quarter 2022. The ASU allows for several different methods of calculating the Allowance for Credit Losses (“ACL”) and based on its analysis of observable data, the Company determined the discounted cash flow method to be the most appropriate for all its loan segments. The Company adopted this guidance on January 1, 2023 and recorded a $3.0 million pre-tax one-time cumulative effect adjustment to the ACL in retained earnings on the consolidated balance sheet as of the beginning of 2023, as is required in the guidance. In addition, the Company recorded a one-time $2.5 million pre-tax cumulative effect adjustment to the allowance for unfunded commitments in retained earnings on the consolidated balance sheet. The qualitative impact of the new accounting standard is directed by many of the same factors that impacted the previous methodology for calculating the ACL, including but not limited to, quality and experience of staff, changes in the value of collateral, concentrations of credit in loan types or industries and changes to lending policies. In addition, the Company also uses reasonable and supportable forecasts. Examples of this are regression analyses of data from the Federal Open Market Committee quarterly economic projections for change in real GDP, housing price index and national unemployment. The following table presents the impact of the adoption of ASC 326 as of January 1, 2023: January 1, 2023 (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption As Reported Under ASC 326 Assets: Commercial loans Commercial and industrial $ 1,711 $ (120) $ 1,591 Owner-occupied commercial real estate 651 62 713 Investor commercial real estate 1,099 (191) 908 Construction 2,074 (435) 1,639 Single tenant lease financing 10,519 (346) 10,173 Public finance 1,753 (135) 1,618 Healthcare finance 2,997 1,034 4,031 Small business lending 2,168 334 2,502 Franchise finance 3,988 (313) 3,675 Total commercial loans 26,960 (110) 26,850 Consumer loans Residential mortgage 1,559 406 1,965 Home equity 69 133 202 Other consumer 3,149 2,533 5,682 Total consumer loans 4,777 3,072 7,849 Total allowance for credit losses $ 31,737 $ 2,962 $ 34,699 Liabilities: Liability for off-balance sheet credit exposures $ — $ 2,504 $ 2,504 The Company also performed an assessment to determine if an allowance for credit loss was needed for available-for-sale and held-to-maturity securities. The Company analyzed available-for-sale securities investment securities that were in an unrealized loss position as of January 1, 2023 and determined the decline in fair value for those securities was not related to credit, but rather related to changes in interest rates and general market conditions. As such, no ACL was recorded for available-for-sale securities. The Company analyzed held-to-maturity securities and recorded a $0.3 million one-time cumulative adjustment to the allowance in retained earnings. ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (March 2020) and ASU 2022-06 - Deferral of sunset Date of Topic 848 In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from the LIBOR on financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2024. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements. ASU 2022-02 - Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (March 2022)

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. • Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. • Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. • In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief . This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. The Company formed a current expected credit losses (“CECL”) working group that discussed implementation matters related to the completeness and accuracy of historical data, model development and corporate governance documentation. The new allowance model estimates credit losses over the expected life of the portfolio and includes a qualitative framework to account for drivers of losses that the quantitative model does not capture. The CECL working group discussed results from parallel model runs for each portfolio segment, assumptions related to unfunded commitments and economic forecast factors. Model validation was completed by an independent third party in the fourth quarter 2022. The ASU allows for several different methods of calculating the Allowance for Credit Losses (“ACL”) and based on its analysis of observable data, the Company determined the discounted cash flow method to be the most appropriate for all its loan segments. The Company adopted this guidance on January 1, 2023 and recorded a $3.0 million pre-tax one-time cumulative effect adjustment to the ACL in retained earnings on the consolidated balance sheet as of the beginning of 2023, as is required in the guidance. In addition, the Company recorded a one-time $2.5 million pre-tax cumulative effect adjustment to the allowance for unfunded commitments in retained earnings on the consolidated balance sheet. The qualitative impact of the new accounting standard is directed by many of the same factors that impacted the previous methodology for calculating the ACL, including but not limited to, quality and experience of staff, changes in the value of collateral, concentrations of credit in loan types or industries and changes to lending policies. In addition, the Company also uses reasonable and supportable forecasts. Examples of this are regression analyses of data from the Federal Open Market Committee quarterly economic projections for change in real GDP, housing price index and national unemployment. The following table presents the impact of the adoption of ASC 326 as of January 1, 2023: January 1, 2023 (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption As Reported Under ASC 326 Assets: Commercial loans Commercial and industrial $ 1,711 $ (120) $ 1,591 Owner-occupied commercial real estate 651 62 713 Investor commercial real estate 1,099 (191) 908 Construction 2,074 (435) 1,639 Single tenant lease financing 10,519 (346) 10,173 Public finance 1,753 (135) 1,618 Healthcare finance 2,997 1,034 4,031 Small business lending 2,168 334 2,502 Franchise finance 3,988 (313) 3,675 Total commercial loans 26,960 (110) 26,850 Consumer loans Residential mortgage 1,559 406 1,965 Home equity 69 133 202 Other consumer 3,149 2,533 5,682 Total consumer loans 4,777 3,072 7,849 Total allowance for credit losses $ 31,737 $ 2,962 $ 34,699 Liabilities: Liability for off-balance sheet credit exposures $ — $ 2,504 $ 2,504 The Company also performed an assessment to determine if an allowance for credit loss was needed for available-for-sale and held-to-maturity securities. The Company analyzed available-for-sale securities investment securities that were in an unrealized loss position as of January 1, 2023 and determined the decline in fair value for those securities was not related to credit, but rather related to changes in interest rates and general market conditions. As such, no ACL was recorded for available-for-sale securities. The Company analyzed held-to-maturity securities and recorded a $0.3 million one-time cumulative adjustment to the allowance in retained earnings. ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (March 2020) and ASU 2022-06 - Deferral of sunset Date of Topic 848 In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from the LIBOR on financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2024. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements. ASU 2022-02 - Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (March 2022)

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. • Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. • Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. • In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief . This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. The Company formed a current expected credit losses (“CECL”) working group that discussed implementation matters related to the completeness and accuracy of historical data, model development and corporate governance documentation. The new allowance model estimates credit losses over the expected life of the portfolio and includes a qualitative framework to account for drivers of losses that the quantitative model does not capture. The CECL working group discussed results from parallel model runs for each portfolio segment, assumptions related to unfunded commitments and economic forecast factors. Model validation was completed by an independent third party in the fourth quarter 2022. The ASU allows for several different methods of calculating the Allowance for Credit Losses (“ACL”) and based on its analysis of observable data, the Company determined the discounted cash flow method to be the most appropriate for all its loan segments. The Company adopted this guidance on January 1, 2023 and recorded a $3.0 million pre-tax one-time cumulative effect adjustment to the ACL in retained earnings on the consolidated balance sheet as of the beginning of 2023, as is required in the guidance. In addition, the Company recorded a one-time $2.5 million pre-tax cumulative effect adjustment to the allowance for unfunded commitments in retained earnings on the consolidated balance sheet. The qualitative impact of the new accounting standard is directed by many of the same factors that impacted the previous methodology for calculating the ACL, including but not limited to, quality and experience of staff, changes in the value of collateral, concentrations of credit in loan types or industries and changes to lending policies. In addition, the Company also uses reasonable and supportable forecasts. Examples of this are regression analyses of data from the Federal Open Market Committee quarterly economic projections for change in real GDP, housing price index and national unemployment. The following table presents the impact of the adoption of ASC 326 as of January 1, 2023: January 1, 2023 (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption As Reported Under ASC 326 Assets: Commercial loans Commercial and industrial $ 1,711 $ (120) $ 1,591 Owner-occupied commercial real estate 651 62 713 Investor commercial real estate 1,099 (191) 908 Construction 2,074 (435) 1,639 Single tenant lease financing 10,519 (346) 10,173 Public finance 1,753 (135) 1,618 Healthcare finance 2,997 1,034 4,031 Small business lending 2,168 334 2,502 Franchise finance 3,988 (313) 3,675 Total commercial loans 26,960 (110) 26,850 Consumer loans Residential mortgage 1,559 406 1,965 Home equity 69 133 202 Other consumer 3,149 2,533 5,682 Total consumer loans 4,777 3,072 7,849 Total allowance for credit losses $ 31,737 $ 2,962 $ 34,699 Liabilities: Liability for off-balance sheet credit exposures $ — $ 2,504 $ 2,504 The Company also performed an assessment to determine if an allowance for credit loss was needed for available-for-sale and held-to-maturity securities. The Company analyzed available-for-sale securities investment securities that were in an unrealized loss position as of January 1, 2023 and determined the decline in fair value for those securities was not related to credit, but rather related to changes in interest rates and general market conditions. As such, no ACL was recorded for available-for-sale securities. The Company analyzed held-to-maturity securities and recorded a $0.3 million one-time cumulative adjustment to the allowance in retained earnings. ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (March 2020) and ASU 2022-06 - Deferral of sunset Date of Topic 848 In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from the LIBOR on financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2024. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements. ASU 2022-02 - Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (March 2022)

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	The following is a reconciliation of the weighted-average common shares for the basic and diluted (loss) earnings per share computations for the three months ended March 31, 2023 and 2022. (dollars in thousands, except per share data) Three Months Ended March 31, 2023 2022 Basic (loss) earnings per share Net (loss) income $ (3,017) $ 11,209 Weighted-average common shares 9,024,072 9,790,122 Basic (loss) earnings per common share $ (0.33) $ 1.14 Diluted (loss) earnings per share Net (loss) income $ (3,017) $ 11,209 Weighted-average common shares 9,024,072 9,790,122 Dilutive effect of equity compensation — 80,272 Weighted-average common and incremental shares 9,024,072 9,870,394 Diluted (loss) earnings per common share 1 $ (0.33) $ 1.14 1 Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Since the Company was in a loss position for the three months ended March 31, 2023, basic net loss is the same as diluted net loss per share, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 661 for the three months ended March 31, 2022.

Securities (Tables)

Securities (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	The following tables summarize securities available-for-sale and securities held-to-maturity as of March 31, 2023 and December 31, 2022. March 31, 2023 Amortized Gross Unrealized Fair (in thousands) Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 38,675 $ 49 $ (1,677) $ 37,047 Municipal securities 69,243 602 (1,209) 68,636 Agency mortgage-backed securities - residential 1 249,795 7 (33,050) 216,752 Agency mortgage-backed securities - commercial 16,739 — (1,209) 15,530 Private label mortgage-backed securities - residential 11,445 — (1,170) 10,275 Asset-backed securities 5,000 — (2) 4,998 Corporate securities 45,623 2 (3,030) 42,595 Total available-for-sale $ 436,520 $ 660 $ (41,347) $ 395,833 December 31, 2022 Amortized Gross Unrealized Fair (in thousands) Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 35,606 $ — $ (1,797) $ 33,809 Municipal securities 68,958 458 (2,140) 67,276 Agency mortgage-backed securities - residential 1 252,066 — (36,974) 215,092 Agency mortgage-backed securities - commercial 17,142 — (1,302) 15,840 Private label mortgage-backed securities - residential 11,777 — (1,322) 10,455 Asset-backed securities 5,000 — (40) 4,960 Corporate securities 45,634 35 (2,717) 42,952 Total available-for-sale $ 436,183 $ 493 $ (46,292) $ 390,384
Schedule Of Held-To-Maturity Securities Reconciliation	March 31, 2023 Amortized Cost Gross Unrealized Fair Value Allowance for Credit Losses Net Carrying Value (in thousands) Gains Losses Securities held-to-maturity Municipal securities $ 13,935 $ 10 $ (801) $ 13,144 $ (3) $ 13,932 Mortgage-backed securities - residential 146,809 11 (13,553) 133,267 — 146,809 Mortgage-backed securities - commercial 5,806 — (1,103) 4,703 — 5,806 Corporate securities 44,547 — (3,198) 41,349 (333) 44,214 Total held-to-maturity $ 211,097 $ 21 $ (18,655) $ 192,463 $ (336) $ 210,761 1 Includes $0.5 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of March 31, 2023. December 31, 2022 Amortized Gross Unrealized Fair (in thousands) Cost Gains Losses Value Securities held-to-maturity Municipal securities $ 13,946 $ — $ (1,114) $ 12,832 Agency mortgage-backed securities - residential 121,853 — (15,112) 106,741 Agency mortgage-backed securities - commercial 5,818 — (1,266) 4,552 Corporate securities 47,551 — (3,193) 44,358 Total held-to-maturity $ 189,168 $ — $ (20,685) $ 168,483 1 Includes $0.5 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of December 31, 2022.
Available-for-sale Securities	The carrying value of securities at March 31, 2023 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Available-for-Sale (in thousands) Amortized Fair Within one year $ 269 $ 263 One to five years 34,401 35,141 Five to ten years 45,784 43,291 After ten years 73,087 69,583 153,541 148,278 Agency mortgage-backed securities - residential 249,795 216,752 Agency mortgage-backed securities - commercial 16,739 15,530 Private label mortgage-backed securities - residential 11,445 10,275 Asset-backed securities 5,000 4,998 Total $ 436,520 $ 395,833
Held-to-maturity Securities	Held-to-Maturity (in thousands) Amortized Fair Within one year $ 495 $ 484 One to five years 8,304 8,107 Five to ten years 44,208 40,910 After ten years 5,475 4,992 58,482 54,493 Agency mortgage-backed securities - residential 146,809 133,267 Agency mortgage-backed securities - commercial 5,806 4,703 Total $ 211,097 $ 192,463
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2023 and December 31, 2022. March 31, 2023 Less Than 12 Months 12 Months or Longer Total (in thousands) Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ 11,764 $ (413) $ 20,681 $ (1,264) $ 32,445 $ (1,677) Municipal securities 32,847 (155) 43,485 (1,054) 76,332 (1,209) Agency mortgage-backed securities- residential 29,536 (3,708) 185,093 (29,342) 214,629 (33,050) Agency mortgage-backed securities- commercial — — 15,530 (1,209) 15,530 (1,209) Private label mortgage-backed securities - residential 127 (15) 10,148 (1,155) 10,275 (1,170) Asset-backed securities — — 4,998 (2) 4,998 (2) Corporate securities 25,769 (857) 14,828 (2,173) 40,597 (3,030) Total $ 100,043 $ (5,148) $ 294,763 $ (36,199) $ 394,806 $ (41,347) December 31, 2022 Less Than 12 Months 12 Months or Longer Total (in thousands) Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ 29,668 $ (1,008) $ 4,141 $ (789) $ 33,809 $ (1,797) Municipal securities 39,557 (1,766) 4,778 (374) 44,335 (2,140) Agency mortgage-backed securities - residential 170,026 (29,690) 45,066 (7,284) 215,092 (36,974) Agency mortgage-backed securities - commercial 10,560 (926) 5,280 (376) 15,840 (1,302) Private label mortgage-backed securities 2,445 (330) 8,010 (992) 10,455 (1,322) Asset-backed securities 4,960 (40) — — 4,960 (40) Corporate securities 21,568 (1,452) 13,239 (1,265) 34,807 (2,717) Total $ 278,784 $ (35,212) $ 80,514 $ (11,080) $ 359,298 $ (46,292) December 31, 2022 Less Than 12 Months 12 Months or Longer Total (in thousands) Fair Unrealized Fair Unrealized Fair Unrealized Securities held-to-maturity Municipal securities $ 8,160 $ (661) $ 4,258 $ (453) $ 12,418 $ (1,114) Agency mortgage-backed securities - residential 68,408 (8,848) 38,332 (6,264) 106,740 (15,112) Agency mortgage-backed securities - commercial 4,552 (1,266) — — 4,552 (1,266) Corporate securities 36,866 (2,685) 7,492 (508) 44,358 (3,193) Total $ 117,986 $ (13,460) $ 50,082 $ (7,225) $ 168,068 $ (20,685) The following table summarizes ratings for the Company’s HTM portfolio issued by state and political subdivisions and other securities as of March 31, 2023. Held-to-Maturity (in thousands) State and Municipal Other Total Aaa/AAA $ 8,684 $ — $ 8,684 Aa1/AA+ 1,271 — 1,271 Aa2/AA 1,540 — 1,540 A1/A+ 1,794 — 1,794 A2/A 646 — 646 A3/A- — 9,517 9,517 Baa1/BBB+ — 9,500 9,500 Baa2/BBB — 11,000 11,000 Baa3/BBB- — 14,530 14,530 Not Rated 1 — 152,615 152,615 Total $ 13,935 $ 197,162 $ 211,097 1 HTM agency mortgage-backed securities - commercial and residential are listed under Other securities as not rated.
Schedule of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive loss, included in shareholders' equity, for the three months ended March 31, 2023 and 2022, respectively, are presented in the table below. (in thousands) Unrealized Losses On Debt Securities Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity Cash Flow Hedges Total Balance, January 1, 2023 $ (35,831) $ (3,519) $ 5,714 $ (33,636) Other comprehensive income (loss) before reclassifications from accumulated other comprehensive loss before tax 5,112 — (2,170) 2,942 Reclassifications from accumulated other comprehensive loss to earnings before tax — 158 — 158 Other comprehensive gain (loss) before tax 5,112 158 (2,170) 3,100 Income tax provision (benefit) 1,170 46 (499) 717 Other comprehensive income (loss) - net of tax 3,942 112 (1,671) 2,383 Balance, March 31, 2023 $ (31,889) $ (3,407) $ 4,043 $ (31,253) Balance, January 1, 2022 $ (2,555) $ — $ (8,484) $ (11,039) Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax (17,881) (5,402) 9,334 (13,949) Reclassifications from accumulated other comprehensive loss to earnings before tax — 119 — 119 Other comprehensive (loss) gain before tax (17,881) (5,283) 9,334 (13,830) Income tax (benefit) provision (4,077) (1,249) 3,318 (2,008) Other comprehensive (loss) income - net of tax (13,804) (4,034) 6,016 (11,822) Balance, March 31, 2022 $ (16,359) $ (4,034) $ (2,468) $ (22,861) Details About Accumulated Other Comprehensive Loss Components Amounts Reclassified from Affected Line Item in the Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Reclassifications from accumulated other comprehensive loss to earnings before tax $ (158) (119) Interest income Total amount reclassified before tax (158) (119) (Loss) income before income taxes Tax benefit (46) (27) Income tax (benefit) provision Total reclassifications from accumulated other comprehensive loss $ (112) $ (92) Net (loss) income

Loans (Tables)

Loans (Tables)	3 Months Ended
	Mar. 31, 2023
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	Loan balances as of March 31, 2023 and December 31, 2022 are summarized in the table below. Categories of loans include: (in thousands) March 31, 2023 December 31, 2022 Commercial loans Commercial and industrial $ 113,198 $ 126,108 Owner-occupied commercial real estate 59,643 61,836 Investor commercial real estate 142,174 93,121 Construction 158,147 181,966 Single tenant lease financing 952,533 939,240 Public finance 604,898 621,032 Healthcare finance 256,670 272,461 Small business lending 136,382 123,750 Franchise finance 382,161 299,835 Total commercial loans 2,805,806 2,719,349 Consumer loans Residential mortgage 392,062 383,948 Home equity 26,160 24,712 Other consumer loans 338,133 324,598 Total consumer loans 756,355 733,258 Total commercial and consumer loans 3,562,161 3,452,607 Net deferred loan origination fees/costs and premiums/discounts on purchased loans and other 1 45,081 46,794 Total loans 3,607,242 3,499,401 Allowance for credit losses (36,879) (31,737) Net loans $ 3,570,363 $ 3,467,664
Financing Receivables, Provision For Credit Losses On Off-Balance Sheet Commitments	The following table details activity in the provision for credit losses on off-balance sheet commitments through March 31, 2023. (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption Provision for credit losses Balance, March 31, 2023 Off-balance sheet commitments Commercial loans Commercial and industrial $ — $ 110 $ 39 $ 149 Owner-occupied commercial real estate — — 8 8 Investor commercial real estate — 9 39 48 Construction — 2,193 (39) 2,154 Healthcare finance — 2 — 2 Total commercial loans — 2,314 47 2,361 Consumer loans Residential mortgage — 127 (14) 113 Home equity — 52 10 62 Other consumer — 11 (1) 10 Total consumer loans — 190 (5) 185 Total allowance for off-balance sheet commitments $ — $ 2,504 $ 42 $ 2,546
Allowance for Credit Losses on Financing Receivables	The following tables present changes in the balance of the ACL during the three months ended March 31, 2023. (in thousands) Three Months Ended March 31, 2023 Allowance for credit losses: Balance, Beginning of Period Adoption of CECL (Credit) Provision Charged to Expense Losses Recoveries Balance, Commercial and industrial $ 1,711 $ (120) $ 6,810 $ (6,965) $ 1 $ 1,437 Owner-occupied commercial real estate 651 62 (1) — — 712 Investor commercial real estate 1,099 (191) 368 — — 1,276 Construction 2,074 (435) (88) — — 1,551 Single tenant lease financing 10,519 (346) 100 — — 10,273 Public finance 1,753 (135) (48) — — 1,570 Healthcare finance 2,997 1,034 (336) — — 3,695 Small business lending 2,168 334 (105) (60) 3 2,340 Franchise finance 3,988 (313) 997 — — 4,672 Residential mortgage 1,559 406 594 — 2 2,561 Home equity 69 133 51 — 1 254 Other consumer loans 3,149 2,533 1,031 (232) 57 6,538 Total $ 31,737 $ 2,962 $ 9,373 $ (7,257) $ 64 $ 36,879 Prior to the adoption of ASU 2016-13 on January 1, 2023, the Company calculated the allowance for loan losses using the incurred loss methodology. The following table presents the activity in the allowance for loan losses by segment for the three months ended March 31, 2022. (in thousands) Three Months Ended March 31, 2022 Allowance for loan losses: Balance, Beginning of Period (Credit) Provision Charged to Expense Losses Recoveries Balance, Commercial and industrial $ 1,891 $ 88 $ — $ — $ 1,979 Owner-occupied commercial real estate 742 (116) — — 626 Investor commercial real estate 328 77 — — 405 Construction 1,612 154 — — 1,766 Single tenant lease financing 10,385 (1,645) — 1,231 9,971 Public finance 1,776 7 — — 1,783 Healthcare finance 5,940 (430) — — 5,510 Small business lending 1,387 111 (80) 17 1,435 Franchise finance 1,083 354 — — 1,437 Residential mortgage 643 87 — 1 731 Home equity 64 (1) — 2 65 Other consumer loans 1,990 263 (163) 99 2,189 Tax refund advance loans — 1,842 (1,488) — 354 Total $ 27,841 $ 791 $ (1,731) $ 1,350 $ 28,251 In addition to the ACL, the Company established a reserve for off-balance sheet commitments, classified in other liabilities, as required by the adoption of the CECL methodology for measuring credit losses. This reserve is maintained at a level management believes to be sufficient to absorb losses arising from unfunded loan commitments. The day one entry for off-balance sheet commitments resulted in a reserve of $2.5 million. The adequacy of the reserve for unfunded commitments is determined quarterly based on methodology similar to the methodology for determining the ACL. The following table details activity in the provision for credit losses on off-balance sheet commitments through March 31, 2023. (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption Provision for credit losses Balance, March 31, 2023 Off-balance sheet commitments Commercial loans Commercial and industrial $ — $ 110 $ 39 $ 149 Owner-occupied commercial real estate — — 8 8 Investor commercial real estate — 9 39 48 Construction — 2,193 (39) 2,154 Healthcare finance — 2 — 2 Total commercial loans — 2,314 47 2,361 Consumer loans Residential mortgage — 127 (14) 113 Home equity — 52 10 62 Other consumer — 11 (1) 10 Total consumer loans — 190 (5) 185 Total allowance for off-balance sheet commitments $ — $ 2,504 $ 42 $ 2,546
Allowance For Credit Losses On Financing Receivables Portfolio Segment	The following table present the recorded investment in loans based on portfolio segment and impairment method as of December 31, 2022. (in thousands) Loans Allowance for Loan Losses December 31, 2022 Ending Balance: Ending Balance: Ending Balance Ending Balance: Ending Balance: Ending Balance Commercial and industrial $ 116,307 $ 9,801 $ 126,108 $ 1,660 $ 51 $ 1,711 Owner-occupied commercial real estate 60,266 1,570 61,836 651 — 651 Investor commercial real estate 93,121 — 93,121 1,099 — 1,099 Construction 181,966 — 181,966 2,074 — 2,074 Single tenant lease financing 939,240 — 939,240 10,519 — 10,519 Public finance 621,032 — 621,032 1,753 — 1,753 Healthcare finance 272,461 — 272,461 2,997 — 2,997 Small business lending 1 113,699 10,051 123,750 1,465 703 2,168 Franchise finance 299,835 — 299,835 3,988 — 3,988 Residential mortgage 380,272 3,676 383,948 1,559 — 1,559 Home equity 24,683 29 24,712 69 — 69 Other consumer 324,581 17 324,598 3,149 — 3,149 Total $ 3,427,463 $ 25,144 $ 3,452,607 $ 30,983 $ 754 $ 31,737 1 Balance is partially guaranteed by the U.S. government.
Financing Receivable Credit Quality Indicators	The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios by loan class and by year of origination for the years indicated based on rating category and payment activity as of March 31, 2023 and December 31, 2022. March 31, 2023 Term Loans (amortized cost basis by origination year) Revolving loans amortized cost basis Revolving loans converted to term (in thousands) 2023 2022 2021 2020 2019 Prior Total Commercial and industrial Pass $ 2,393 $ 33,609 $ 15,988 $ 2,648 $ 12,826 $ 12,471 $ 29,091 $ — $ 109,026 Special Mention — 36 918 — — — 382 — 1,336 Substandard — — 2,836 — — — — — 2,836 Doubtful — — — — — — — — — Total Commercial and 2,393 33,645 19,742 2,648 12,826 12,471 29,473 — 113,198 Gross charge-offs — — 6,914 — 51 — — — 6,965 Owner-occupied commercial real estate Pass 411 11,447 9,251 6,748 6,132 14,753 — — 48,742 Special Mention — — — 8,568 — 892 — — 9,460 Substandard — — — — — 1,441 — — 1,441 Doubtful — — — — — — — — — Total owner-occupied 411 11,447 9,251 15,316 6,132 17,086 — — 59,643 Investor commercial real estate Pass 4,878 40,758 23,893 10,049 48,544 6,169 — — 134,291 Special Mention — — — — — 7,883 — — 7,883 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total investor commercial real 4,878 40,758 23,893 10,049 48,544 14,052 — — 142,174 Construction Pass 785 80,984 34,384 38,905 — 640 973 — 156,671 Special Mention — — 1,476 — — — — — 1,476 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total construction 785 80,984 35,860 38,905 — 640 973 — 158,147 Single tenant lease financing Pass 25,137 230,780 98,253 71,375 147,335 376,515 — — 949,395 Special Mention — — — — — 3,138 — — 3,138 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total single tenant lease 25,137 230,780 98,253 71,375 147,335 379,653 — — 952,533 Public finance Pass 861 79,566 31,950 7,722 48,759 433,760 — — 602,618 Special Mention — — — — — 2,280 — — 2,280 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total public finance 861 79,566 31,950 7,722 48,759 436,040 — — 604,898 March 31, 2023 Term Loans (amortized cost basis by origination year) Revolving loans amortized cost basis Revolving loans converted to term (in thousands) 2023 2022 2021 2020 2019 Prior Total Healthcare finance Pass — — 11,609 143,651 72,756 27,327 — — 255,343 Special Mention — — — — 1,327 — — — 1,327 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total healthcare finance — — 11,609 143,651 74,083 27,327 — — 256,670 Small business lending 1 Pass 19,718 49,970 17,396 16,991 5,369 14,320 2,470 — 126,234 Special Mention — 343 123 1,717 714 2,078 150 — 5,125 Substandard — 780 716 1,445 800 1,185 97 — 5,023 Doubtful — — — — — — — — — Total small business lending 19,718 51,093 18,235 20,153 6,883 17,583 2,717 — 136,382 Gross charge-offs — — — 60 — — — — 60 Franchise finance Pass 78,796 237,658 65,129 — — — — — 381,583 Special Mention — — 578 — — — — — 578 Substandard — — — — — — — — — Doubtful — — — — — — — — — Total franchise finance 78,796 237,658 65,707 — — — — — 382,161 Consumer loans Residential mortgage Payment performance Performing 4,207 191,584 98,095 34,312 12,303 50,555 — — 391,056 Nonperforming — 235 — 76 — 695 — — 1,006 Total residential mortgage 4,207 191,819 98,095 34,388 12,303 51,250 — — 392,062 Home equity Payment performance Performing 2,463 10,080 3,903 3,518 780 3,709 1,707 — 26,160 Nonperforming — — — — — — — — — Total home equity 2,463 10,080 3,903 3,518 780 3,709 1,707 — 26,160 Other consumer Payment performance Performing 29,138 120,846 49,726 31,542 32,736 73,230 774 — 337,992 Nonperforming — 54 — — 54 33 — — 141 Total other consumer 29,138 120,900 49,726 31,542 32,790 73,263 774 — 338,133 Gross charge-offs — 35 7 8 107 75 — — 232 Total Loans $ 168,787 $ 1,088,730 $ 466,224 $ 379,267 $ 390,435 $ 1,033,074 $ 35,644 $ — $ 3,562,161 Total gross charge-offs $ — $ 35 $ 6,921 $ 68 $ 158 $ 75 $ — $ — $ 7,257 1 Balance in “Substandard” is partially guaranteed by the U.S. government. The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of December 31, 2022. December 31, 2022 (in thousands) Pass Special Mention Substandard Total Commercial and industrial $ 114,934 1,373 $ 9,801 $ 126,108 Owner-occupied commercial real estate 50,721 9,546 1,569 61,836 Investor commercial real estate 93,121 — — 93,121 Construction 180,768 1,198 — 181,966 Single tenant lease financing 936,207 3,033 — 939,240 Public finance 618,752 2,280 — 621,032 Healthcare finance 271,085 1,376 — 272,461 Small business lending 1 107,885 5,814 $ 10,051 123,750 Franchise finance 299,241 594 $ — 299,835 Wealth advisory lending — — — — Total loans $ 2,672,714 $ 25,214 $ 21,421 $ 2,719,349 1 Balance in “Substandard” is partially guaranteed by the U.S. government. December 31, 2022 (in thousands) Performing Nonaccrual Total Residential mortgage $ 382,900 $ 1,048 $ 383,948 Home equity 24,712 — 24,712 Other consumer 324,581 17 324,598 Total consumer loans $ 732,193 $ 1,065 $ 733,258
Past Due Financing Receivables	The following tables present the Company’s loan portfolio delinquency analysis as of March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) 30-59 60-89 90 Days Total Current Total Commercial and industrial $ — $ — $ — $ — $ 113,198 $ 113,198 Owner-occupied commercial real estate — — — — 59,643 59,643 Investor commercial real estate — — — — 142,174 142,174 Construction — — — — 158,147 158,147 Single tenant lease financing — — — — 952,533 952,533 Public finance — — — — 604,898 604,898 Healthcare finance — — — — 256,670 256,670 Small business lending 1 55 1,426 2,354 3,835 132,547 136,382 Franchise finance — — — — 382,161 382,161 Residential mortgage 301 234 235 770 391,292 392,062 Home equity — — — — 26,160 26,160 Other consumer 78 38 35 151 337,982 338,133 Total $ 434 $ 1,698 $ 2,624 $ 4,756 $ 3,557,405 $ 3,562,161 1 Balance is partially guaranteed by the U.S. government. December 31, 2022 (in thousands) 30-59 60-89 90 Days Total Current Total Commercial and industrial $ 81 $ — $ 51 $ 132 $ 125,976 $ 126,108 Owner-occupied commercial real estate — — — — 61,836 61,836 Investor commercial real estate — — — — 93,121 93,121 Construction — 1,198 — 1,198 180,768 181,966 Single tenant lease financing — — — — 939,240 939,240 Public finance — — — — 621,032 621,032 Healthcare finance — — — — 272,461 272,461 Small business lending 1 57 — 3,485 3,542 120,208 123,750 Franchise Finance 313 — — 313 299,522 299,835 Residential mortgage — 283 185 468 383,480 383,948 Home equity — — — — 24,712 24,712 Other consumer 91 10 — 101 324,497 324,598 Total $ 542 $ 1,491 $ 3,721 $ 5,754 $ 3,446,853 $ 3,452,607 1 Balance is partially guaranteed by the U.S. government. Loans are reclassified to a non-accruing status when, in management’s judgment, the collateral value and financial condition of the borrower do not justify accruing interest. At the time the accrual is discontinued, all unpaid accrued interest is reversed against earnings. Interest income accrued in prior years, if any, is charged to the allowance for credit losses. Payments subsequently received on nonaccrual loans are applied to principal. A loan is returned to accrual status when principal and interest are no longer past due and collectability is probable, typically after a minimum of six consecutive months of performance. The following table summarizes the Company’s nonaccrual loans and loans past due 90 days or more and still accruing by loan class for the periods indicated: March 31, 2023 December 31, 2022 (in thousands) Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Losses Total Loans Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Losses Total Loans Commercial and industrial $ 2,836 $ 2,836 $ — $ 51 $ — $ — Owner-occupied commercial real estate 1,441 1,441 — 1,570 1,570 — Small business lending 1 3,797 2,354 — 4,764 2,766 — Residential mortgage 1,006 1,006 — 1,048 1,048 79 Other consumer 141 141 — 17 17 — Total loans $ 9,221 $ 7,778 $ — $ 7,450 $ 5,401 $ — 1 Balance is partially guaranteed by the U.S. government.
Impaired Financing Receivables	The following table presents the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses as of March 31, 2023, March 31, 2023 (in thousands) Commercial Real Estate Residential Real Estate Other Total Allowance on Collateral Dependent Loans Commercial and industrial $ — $ — $ 2,836 $ 2,836 $ — Owner-occupied commercial real estate — — 1,441 1,441 — Small business lending 1 2,147 395 877 3,419 603 Residential mortgage — 1,006 — 1,006 — Other consumer loans — — 141 141 — Total loans $ 2,147 $ 1,401 $ 5,295 $ 8,843 $ 603 1 Balance is partially guaranteed by the U.S. government. The following table presents the Company’s impaired loans as of December 31, 2022. December 31, 2022 (in thousands) Recorded Unpaid Specific Loans without a specific valuation allowance Commercial and industrial $ 9,750 $ 9,750 $ — Owner-occupied commercial real estate 1,570 1,779 — Small business lending 8,184 8,705 — Residential mortgage 3,676 3,835 — Home equity 29 29 — Other consumer loans 17 36 — Total 23,226 24,134 — Loans with a specific valuation allowance Commercial and industrial 51 51 51 Small business lending 1 1,867 1,867 703 Total 1,918 1,918 754 Total impaired loans $ 25,144 $ 26,052 $ 754 Three Months Ended March 31, 2022 (in thousands) Average Interest Loans without a specific valuation allowance Owner-occupied commercial real estate 3,307 — Small business lending 830 — Residential mortgage 3,273 8 Home equity 14 — Other consumer loans 10 — Total 7,434 8 Loans with a specific valuation allowance Commercial and industrial 627 — Single tenant lease financing 1,094 — Healthcare finance 918 17 Small business lending 1 1,333 — Total 3,972 17 Total impaired loans $ 11,406 $ 25 1 Balance is partially guaranteed by the U.S. government.

Premises and Equipment (Tables)

Premises and Equipment (Tables)	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	The following table summarizes premises and equipment at March 31, 2023 and December 31, 2022. (in thousands) March 31, December 31, Land $ 5,598 $ 5,598 Construction in process 177 714 Right of use leased asset 160 206 Building and improvements 60,199 57,505 Furniture and equipment 19,995 19,585 Less: accumulated depreciation (11,881) (10,897) Total $ 74,248 $ 72,711

Servicing Asset (Tables)

Servicing Asset (Tables)	3 Months Ended
	Mar. 31, 2023
Transfers and Servicing [Abstract]
Schedule of Servicing Assets at Fair Value	Activity for the servicing asset and the related changes in fair value for the three months ended March 2023 and 2022 are shown in the table below. Three Months Ended (in thousands) March 31, 2023 March 31, 2022 Balance, beginning of period $ 6,255 $ 4,702 Additions: Originated and purchased servicing 1,112 844 Subtractions Paydowns: (339) (256) Changes in fair value due to changes in valuation inputs or assumptions used in 284 (41) Loan servicing asset revaluation $ (55) $ (297) Balance, end of period $ 7,312 $ 5,249
Schedule Of Unpaid Principal Balances Of Loans Serviced For Others	The unpaid principal balances of these loans serviced for others as of March 31, 2023 and December 31, 2022 are shown in the table below. (in thousands) March 31, 2023 December 31, 2022 Loan portfolios serviced for: SBA guaranteed loans $ 356,808 $ 318,194 Total $ 356,808 $ 318,194

Subordinated Debt (Tables)

Subordinated Debt (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Subordinated Borrowing	March 31, 2023 December 31, 2022 (in thousands) Principal Unamortized Debt Issuance Costs Principal Unamortized Debt Issuance Costs 2029 Notes $ 37,000 $ (981) $ 37,000 $ (1,020) 2030 Notes 10,000 (178) 10,000 (184) 2031 Notes 60,000 (1,233) 60,000 (1,264) Total $ 107,000 $ (2,392) $ 107,000 $ (2,468)

Benefit Plans (Tables)

Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2023
Retirement Benefits [Abstract]
Nonvested Restricted Stock Shares Activity	The following table summarizes the stock-based award activity under the 2022 Plan for the three months ended March 31, 2023. Restricted Stock Units Weighted-Average Grant Date Fair Value Per Share Restricted Stock Awards Weighted-Average Grant Date Fair Value Per Share Deferred Stock Units Weighted-Average Grant Date Fair Value Per Share Unvested at December 31, 2022 — $ — 3,558 $ 36.84 — $ — Granted 71,660 24.75 — — — — Unvested at March 31, 2023 71,660 $ 24.75 3,558 $ 36.84 — $ — The following table summarizes the stock-based award activity under the 2013 Plan for the three months ended March 31, 2023. Restricted Stock Units Weighted-Average Grant Date Fair Value Per Share Restricted Stock Awards Weighted-Average Grant Date Fair Value Per Share Deferred Stock Units Weighted-Average Grant Date Fair Value Per Share Unvested at December 31, 2022 101,734 $ 35.93 — $ — — $ — Granted — — — — — — Cancelled/Forfeited (278) 27.56 — — — — Vested (35,808) 31.87 — — — — Unvested at March 31, 2023 65,648 $ 38.18 — $ — — $ —
Schedule Of Deferred Stock Option Plan	The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the three months ended March 31, 2023. Deferred Stock Rights Outstanding, beginning of period 40,414 Granted 100 Outstanding, end of period 40,514

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis	The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 37,047 $ — $ 37,047 $ — Municipal securities 68,636 — 68,636 — Agency mortgage-backed securities - residential 216,752 — 216,752 — Agency mortgage-backed securities - commercial 15,530 — 15,530 — Private label mortgage-backed securities - residential 10,275 — 10,275 — Asset-backed securities 4,998 — 4,998 — Corporate securities 42,595 — 42,595 — Total available-for-sale securities $ 395,833 $ — $ 395,833 $ — Loans held-for-sale (mandatory pricing agreements) 2,209 — 2,209 — Servicing asset 7,312 — — 7,312 Interest rate swap assets 6,089 — 6,089 — Forward contracts (22) (22) — — IRLCs — — — — December 31, 2022 (in thousands) Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 33,809 $ — $ 33,809 $ — Municipal securities 67,276 — 67,276 — Agency mortgage-backed securities - residential 215,092 — 215,092 — Agency mortgage-backed securities - commercial 15,840 — 15,840 — Private label mortgage-backed securities - residential 10,455 — 10,455 — Asset-backed securities 4,960 — 4,960 — Corporate securities 42,952 — 42,952 — Total available-for-sale securities $ 390,384 $ — $ 390,384 $ — Loans held-for-sale (mandatory pricing agreements) 9,110 — 9,110 — Servicing asset 6,255 — — 6,255 Interest rate swap agreements 8,645 — 8,645 — Forward contracts 97 97 — — IRLCs 133 — — 133
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three months ended March 31, 2023 and 2022. Three Months Ended (in thousands) Servicing Asset Interest Rate Lock Balance, January 1, 2023 $ 6,255 $ 133 Total realized gains Additions: Originated and purchased servicing 1,112 — Subtractions: Paydowns (339) — Change in fair value 284 (133) Balance, March 31, 2023 $ 7,312 $ — Balance as of January 1, 2022 $ 4,702 $ 718 Total realized gains Additions: Originated and purchased servicing 844 — Subtractions: Paydowns (256) — Change in fair value (41) (806) Balance, March 31, 2022 $ 5,249 $ (88)
Schedule Of Impaired Loans, Including Valuation Allowance, Fair Value, Unobservable Inputs Reconciliation	The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) Fair Value Measurements Using Fair Quoted Prices Significant Significant Collateral dependent loans $ 3,676 $ — $ — $ 3,676 December 31, 2022 (in thousands) Fair Value Measurements Using Fair Quoted Prices Significant Significant Impaired loans $ 1,164 $ — $ — $ 1,164
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements. (dollars in thousands) Fair Value at Valuation Significant Unobservable Range Weighted-Average Range Collateral dependent loans $ 3,676 Fair value of collateral Discount for type of property and current market conditions 4% - 25% 12% Servicing asset 7,312 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 14% 11.5% 14% (dollars in thousands) Fair Value at Valuation Significant Unobservable Range Weighted-Average Range Impaired loans $ 1,164 Fair value of collateral Discount for type of property and current market conditions 0% - 25% 20% IRLCs 133 Discounted cash flow Loan closing rates 31% - 100% 89% Servicing asset 6,255 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 14% 14.6% 14%
Fair Value, by Balance Sheet Grouping	The following tables present the carrying value and estimated fair value of all financial assets and liabilities that are not measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022. March 31, 2023 (in thousands) Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 303,972 $ 303,972 $ 303,972 $ — $ — Securities held-to-maturity, net 210,761 192,463 — 192,463 — Loans held-for-sale (best efforts pricing agreements) 15,935 15,935 — 15,935 — Net loans 3,570,363 3,378,228 — — 3,378,228 Accrued interest receivable 22,322 22,322 22,322 — — Federal Home Loan Bank of Indianapolis stock 28,350 28,350 — 28,350 — Deposits 3,622,290 3,589,180 1,778,865 — 1,810,315 Advances from Federal Home Loan Bank 614,929 601,563 — 601,563 — Subordinated debt 104,608 101,550 31,450 70,100 — Accrued interest payable 2,592 2,592 2,592 — — December 31, 2022 (in thousands) Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 256,552 $ 256,552 $ 256,552 $ — $ — Securities held-to-maturity 189,168 168,483 — 168,483 — Loans held-for-sale (best efforts pricing agreements) 12,401 12,401 — 12,401 — Net loans 3,467,664 3,225,845 — — 3,225,845 Accrued interest receivable 21,069 21,069 21,069 — — Federal Home Loan Bank of Indianapolis stock 28,350 28,350 — 28,350 — Deposits 3,441,245 3,415,390 1,974,344 — 1,441,046 Advances from Federal Home Loan Bank 614,928 596,455 — 596,455 — Subordinated debt 104,532 102,669 32,560 70,109 — Accrued interest payable 2,913 2,913 2,913 — —

Mortgage Banking Activities (Ta

Mortgage Banking Activities (Tables)	3 Months Ended
	Mar. 31, 2023
Mortgage Banking [Abstract]
Schedule of Participating Mortgage Loans	The following table presents the components of income from mortgage banking activities for the three months ended March 31, 2023 and 2022. Three Months Ended March 31, (in thousands) 2023 2022 Gain on loans sold $ 464 $ 2,062 Loss resulting from the change in fair value of loans held-for-sale (136) (489) (Loss) gain resulting from the change in fair value of derivatives (252) 300 Net revenue from mortgage banking activities $ 76 $ 1,873

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule Of Derivative Instruments, Cumulative Basis Adjustments	The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of March 31, 2023 and December 31, 2022. (in thousands) Carrying amount of the hedged asset Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets Line item in the condensed consolidated balance sheets in which the hedged item is included March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Securities available-for-sale 1 $ 69,243 $ 68,963 $ (1,707) $ (2,088) 1 These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The designated hedged items were $50.0 million at both March 31, 2023 and December 31, 2022.
Schedule Of Derivative Instruments Of Fixed Rate Receivables	The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at March 31, 2023 and December 31, 2022, identified by the underlying interest rate-sensitive instruments. (dollars in thousands) March 31, 2023 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Instruments Associated With Fair Value Receive Pay Securities available-for-sale $ 50,000 1.6 $ 1,707 3-month LIBOR 2.33 % Total at March 31, 2023 $ 50,000 1.6 $ 1,707 3-month LIBOR 2.33 % (dollars in thousands) December 31, 2022 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Instruments Associated With Fair Value Receive Pay Securities available-for-sale $ 50,000 1.8 $ 2,093 3-month LIBOR 2.33 % Total swap portfolio at December 31, 2022 $ 50,000 1.8 $ 2,093 3-month LIBOR 2.33 %
Schedule Of Derivative Instruments Of Variable Rate Liabilities	The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at March 31, 2023 and December 31, 2022. (dollars in thousands) March 31, 2023 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Cash Flow Hedges Fair Value Receive Pay Interest rate swaps $ 110,000 3.8 $ 3,126 3-month LIBOR 2.88 % Interest rate swaps 60,000 0.4 473 1-month LIBOR 2.88 % Interest rate swaps 40,000 1.2 783 Fed Funds Effective 2.78 % (dollars in thousands) December 31, 2022 Notional Value Weighted- Average Remaining Maturity (years) Weighted-Average Ratio Cash Flow Hedges Fair Value Receive Pay Interest rate swaps $ 110,000 4.1 $ 4,787 3-month LIBOR 2.88 % Interest rate swaps 60,000 0.6 735 1-month LIBOR 2.88 % Interest rate swaps 40,000 1.4 1,030 Fed Funds Effective 2.78 %
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at March 31, 2023 and December 31, 2022. March 31, 2023 December 31, 2022 (in thousands) Notional Fair Notional Fair Asset Derivatives Derivatives designated as hedging instruments Interest rate swaps associated with securities available-for-sale $ 50,000 $ 1,707 $ 50,000 $ 2,093 Interest rate swaps associated with liabilities 210,000 4,382 210,000 6,552 Derivatives not designated as hedging instruments IRLCs — — 14,862 133 Forward contracts — — 17,000 97 Total contracts $ 260,000 $ 6,089 $ 291,862 $ 8,875 Liability Derivatives Derivatives not designated as hedging instruments Forward contracts $ 1,750 $ (22) $ — $ — Total contracts $ 1,750 $ (22) $ — $ —
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three months ended March 31, 2023 and 2022. Amount of Gain /(Loss) Recognized in Other Comprehensive Income (Loss) in The Three Months Ended (in thousands) March 31, 2023 March 31, 2022 Interest rate swap agreements $ (2,170) $ 9,334
Schedule of Derivative Instruments in Statements of Income Fair Value	The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three months ended March 31, 2023 and 2022. Amount of Gain / (Loss) Recognized in the Three Months Ended (in thousands) March 31, 2023 March 31, 2022 Asset Derivatives Derivatives not designated as hedging instruments IRLCs $ — $ — Forward contracts — 1,102 Liability Derivatives Derivatives not designated as hedging instruments IRLCs $ (133) $ (802) Forward contracts (119) —
Schedule Of Effects Of Interest Rate Swap Agreements On Statements Of Income	The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of operations during the three months ended March 31, 2023 and 2022. (in thousands) Line item in the condensed consolidated statements of operations Three Months Ended March 31, 2023 March 31, 2022 Interest income Securities - taxable $ — $ — Securities - non-taxable 294 (260) Total interest income 294 (260) Interest expense Deposits (418) 670 Other borrowed funds (522) 696 Total interest expense (940) 1,366 Net interest income $ 1,234 $ (1,626)

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive loss, included in shareholders' equity, for the three months ended March 31, 2023 and 2022, respectively, are presented in the table below. (in thousands) Unrealized Losses On Debt Securities Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity Cash Flow Hedges Total Balance, January 1, 2023 $ (35,831) $ (3,519) $ 5,714 $ (33,636) Other comprehensive income (loss) before reclassifications from accumulated other comprehensive loss before tax 5,112 — (2,170) 2,942 Reclassifications from accumulated other comprehensive loss to earnings before tax — 158 — 158 Other comprehensive gain (loss) before tax 5,112 158 (2,170) 3,100 Income tax provision (benefit) 1,170 46 (499) 717 Other comprehensive income (loss) - net of tax 3,942 112 (1,671) 2,383 Balance, March 31, 2023 $ (31,889) $ (3,407) $ 4,043 $ (31,253) Balance, January 1, 2022 $ (2,555) $ — $ (8,484) $ (11,039) Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax (17,881) (5,402) 9,334 (13,949) Reclassifications from accumulated other comprehensive loss to earnings before tax — 119 — 119 Other comprehensive (loss) gain before tax (17,881) (5,283) 9,334 (13,830) Income tax (benefit) provision (4,077) (1,249) 3,318 (2,008) Other comprehensive (loss) income - net of tax (13,804) (4,034) 6,016 (11,822) Balance, March 31, 2022 $ (16,359) $ (4,034) $ (2,468) $ (22,861) Details About Accumulated Other Comprehensive Loss Components Amounts Reclassified from Affected Line Item in the Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Reclassifications from accumulated other comprehensive loss to earnings before tax $ (158) (119) Interest income Total amount reclassified before tax (158) (119) (Loss) income before income taxes Tax benefit (46) (27) Income tax (benefit) provision Total reclassifications from accumulated other comprehensive loss $ (112) $ (92) Net (loss) income

Recent Accounting Pronounceme_3

Recent Accounting Pronouncements (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Accounting Standards Update and Change in Accounting Principle	The following table presents the impact of the adoption of ASC 326 as of January 1, 2023: January 1, 2023 (dollars in thousands) Pre-ASC 326 Adoption Impact of ASC 326 Adoption As Reported Under ASC 326 Assets: Commercial loans Commercial and industrial $ 1,711 $ (120) $ 1,591 Owner-occupied commercial real estate 651 62 713 Investor commercial real estate 1,099 (191) 908 Construction 2,074 (435) 1,639 Single tenant lease financing 10,519 (346) 10,173 Public finance 1,753 (135) 1,618 Healthcare finance 2,997 1,034 4,031 Small business lending 2,168 334 2,502 Franchise finance 3,988 (313) 3,675 Total commercial loans 26,960 (110) 26,850 Consumer loans Residential mortgage 1,559 406 1,965 Home equity 69 133 202 Other consumer 3,149 2,533 5,682 Total consumer loans 4,777 3,072 7,849 Total allowance for credit losses $ 31,737 $ 2,962 $ 34,699 Liabilities: Liability for off-balance sheet credit exposures $ — $ 2,504 $ 2,504

Basis of Presentation (Details)

Basis of Presentation (Details) $ in Thousands	Mar. 31, 2023 USD ($) subsidiary	Jan. 01, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of wholly-owned subsidiaries | subsidiary	3
Total shareholders’ equity	$ 355,572		$ 364,974	$ 374,655	$ 380,338
Net loans	3,570,363		3,467,664
Liability for off-balance sheet credit exposures			0
Held-to-maturity, debt securities, allowance for credit loss	336
Accrued interest, held to maturity	800
Accrued interest, financing receivables	17,700
Accrued interest, available for sale	2,000
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity	$ 197,623		205,675	$ 183,043	$ 172,431
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity			(4,491)
Net loans			2,300
Liability for off-balance sheet credit exposures		$ 2,504	1,900
Held-to-maturity, debt securities, allowance for credit loss			300
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity			$ (4,491)

Basis of Presentation - Narrati

Basis of Presentation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jan. 01, 2023	Dec. 31, 2022	Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity	$ 355,572	$ 374,655		$ 364,974	$ 380,338
Liability for off-balance sheet credit exposures				0
Net (loss) income	(3,017)	11,209
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity	197,623	183,043		205,675	$ 172,431
Net (loss) income	$ (3,017)	$ 11,209
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity				(4,491)
Liability for off-balance sheet credit exposures			$ 2,504	1,900
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total shareholders’ equity				$ (4,491)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Basic (loss) earnings per share
Net (loss) income	$ (3,017)	$ 11,209
Weighted-average common shares (in shares)	9,024,072,000	9,790,122,000
Basic earnings per common share ( in dollars per share)	$ (0.33)	$ 1.14
Diluted (loss) earnings per share
Net (loss) income	$ (3,017)	$ 11,209
Weighted-average common shares (in shares)	9,024,072,000	9,790,122,000
Dilutive effect of equity compensation (in shares)	0	80,272,000
Weighted-average common and incremental shares (in shares)	9,024,072,000	9,870,394,000
Diluted earnings per common share (in dollars per share)	$ (0.33)	$ 1.14
Antidilutive securities excluded from computation of earnings per share, amount (in shares)		661

Securities (Details)

Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Available-for-sale Securities [Abstract]
Amortized cost	$ 436,520	$ 436,183
Gross Unrealized Gains	660	493
Gross Unrealized Losses	(41,347)	(46,292)
Fair Value	395,833	390,384
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	211,097	189,168
Held-to-maturity securities, Gross Unrealized Gains	21	0
Held-to-maturity securities, Gross Unrealized Losses	(18,655)	(20,685)
Held-to-maturity, at fair value	192,463	168,483
Held-to-maturity, debt securities, allowance for credit loss	(336)
Held-to-maturity, debt securities, after allowance for credit loss	210,761	189,168
Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	395,833	390,384
U.S. Government-sponsored agencies
Available-for-sale Securities [Abstract]
Amortized cost	38,675	35,606
Gross Unrealized Gains	49	0
Gross Unrealized Losses	(1,677)	(1,797)
Fair Value	37,047	33,809
U.S. Government-sponsored agencies | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	37,047	33,809
Municipal securities
Available-for-sale Securities [Abstract]
Amortized cost	69,243	68,958
Gross Unrealized Gains	602	458
Gross Unrealized Losses	(1,209)	(2,140)
Fair Value	68,636	67,276
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	13,935	13,946
Held-to-maturity securities, Gross Unrealized Gains	10	0
Held-to-maturity securities, Gross Unrealized Losses	(801)	(1,114)
Held-to-maturity, at fair value	13,144	12,832
Held-to-maturity, debt securities, allowance for credit loss	(3)
Held-to-maturity, debt securities, after allowance for credit loss	13,932
Municipal securities | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	68,636	67,276
Agency mortgage-backed securities - residential 1
Available-for-sale Securities [Abstract]
Amortized cost	249,795	252,066
Gross Unrealized Gains	7	0
Gross Unrealized Losses	(33,050)	(36,974)
Fair Value	216,752	215,092
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	146,809	121,853
Held-to-maturity securities, Gross Unrealized Gains		0
Held-to-maturity securities, Gross Unrealized Losses		(15,112)
Held-to-maturity, at fair value	133,267	106,741
Discount (premium) on debt securities	500
Agency mortgage-backed securities - residential 1 | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value		215,092
Agency mortgage-backed securities - commercial
Available-for-sale Securities [Abstract]
Amortized cost	16,739	17,142
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1,209)	(1,302)
Fair Value	15,530	15,840
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	5,806	5,818
Held-to-maturity securities, Gross Unrealized Gains	0	0
Held-to-maturity securities, Gross Unrealized Losses	(1,103)	(1,266)
Held-to-maturity, at fair value	4,703	4,552
Held-to-maturity, debt securities, allowance for credit loss	0
Held-to-maturity, debt securities, after allowance for credit loss	5,806
Agency mortgage-backed securities - commercial | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	15,530	15,840
Private label mortgage-backed securities - residential
Available-for-sale Securities [Abstract]
Amortized cost	11,445	11,777
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1,170)	(1,322)
Fair Value	10,275	10,455
Asset-backed securities
Available-for-sale Securities [Abstract]
Amortized cost	5,000	5,000
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(2)	(40)
Fair Value	4,998	4,960
Asset-backed securities | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	4,998	4,960
Corporate securities
Available-for-sale Securities [Abstract]
Amortized cost	45,623	45,634
Gross Unrealized Gains	2	35
Gross Unrealized Losses	(3,030)	(2,717)
Fair Value	42,595	42,952
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	44,547	47,551
Held-to-maturity securities, Gross Unrealized Gains	0	0
Held-to-maturity securities, Gross Unrealized Losses	(3,198)	(3,193)
Held-to-maturity, at fair value	41,349	44,358
Held-to-maturity, debt securities, allowance for credit loss	(333)
Held-to-maturity, debt securities, after allowance for credit loss	44,214
Corporate securities | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	42,595	$ 42,952
Mortgage-backed securities - residential
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	146,809
Held-to-maturity securities, Gross Unrealized Gains	11
Held-to-maturity securities, Gross Unrealized Losses	(13,553)
Held-to-maturity, at fair value	133,267
Held-to-maturity, debt securities, allowance for credit loss	0
Held-to-maturity, debt securities, after allowance for credit loss	$ 146,809

Securities (Details Textual)

Securities (Details Textual)	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($) security	Dec. 31, 2021	Dec. 31, 2022 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Held-to-maturity, debt securities, allowance for credit loss	$ 336,000
Available-for-sale securities, gross realized gain (loss)	0
Continuous unrealized loss position, fair value	$ 573,400,000		$ 527,400,000
Continuous unrealized loss position, fair value (as a percent)	97%	94%
Number of securities in portfolio | security	459
Securities in unrealized loss position | security	431
Accrued interest, available for sale	$ 2,000,000
Accrued interest, held to maturity	$ 800,000
Cumulative Effect, Period of Adoption, Adjustment
Debt Securities, Available-for-Sale [Line Items]
Held-to-maturity, debt securities, allowance for credit loss			$ 300,000

Securities - Carrying Value (De

Securities - Carrying Value (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Amortized Cost
Within one year	$ 269
One to five years	34,401
Five to ten years	45,784
After ten years	73,087
Amortized Cost	153,541
Amortized cost	436,520	$ 436,183
Held-to-maturity securities, within one year	495
Held-to-maturity securities, One to five years	8,304
Held-to-maturity securities, Five to ten years	44,208
Held-to-maturity securities, After ten years	5,475
Held-to-maturity securities, Amortized Cost			$ 58,482
Debt Securities, Held-to-maturity	211,097	189,168
Fair Value
Within one year	263
One to five years	35,141
Five to ten years	43,291
After ten years	69,583
Fair Value	148,278
Fair Value	395,833	390,384
Held-to-maturity securities, within one year	484
Held-to-maturity securities, One to five years	8,107
Held-to-maturity securities, Five to ten years	40,910
Held-to-maturity securities, After ten years	4,992
Held-to-maturity securities, Fair Value			$ 54,493
Held-to-maturity, at fair value	192,463	168,483
Agency mortgage-backed securities - residential 1
Amortized Cost
Amortized cost	249,795	252,066
Debt Securities, Held-to-maturity	146,809	121,853
Fair Value
Fair Value	216,752	215,092
Held-to-maturity, at fair value	133,267	106,741
Private label mortgage-backed securities - residential
Amortized Cost
Amortized cost	11,445	11,777
Fair Value
Fair Value	10,275	10,455
Asset-backed securities
Amortized Cost
Amortized cost	5,000	5,000
Fair Value
Fair Value	$ 4,998	$ 4,960

Securities - Gross Unrealized L

Securities - Gross Unrealized Losses and Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Less Than 12 Months, Fair Value	$ 100,043	$ 278,784
Less Than 12 Months, Unrealized Losses	(5,148)	(35,212)
12 Months or Longer, Fair Value	294,763	80,514
12 Months or Longer, Unrealized Losses	(36,199)	(11,080)
Total, Fair Value	394,806	359,298
Total, Unrealized Losses	(41,347)	(46,292)
Held-to-maturity securities, Less Than 12 Months, Fair Value		117,986
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses		(13,460)
Held-to-maturity securities, 12 Months or Longer, Fair Value		50,082
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses		(7,225)
Held-to-maturity securities, Total, Fair Value		168,068
Held-to-maturity securities, Total, Unrealized Losses		(20,685)
U.S. Government-sponsored agencies
Less Than 12 Months, Fair Value	11,764	29,668
Less Than 12 Months, Unrealized Losses	(413)	(1,008)
12 Months or Longer, Fair Value	20,681	4,141
12 Months or Longer, Unrealized Losses	(1,264)	(789)
Total, Fair Value	32,445	33,809
Total, Unrealized Losses	(1,677)	(1,797)
Municipal securities
Less Than 12 Months, Fair Value	32,847	39,557
Less Than 12 Months, Unrealized Losses	(155)	(1,766)
12 Months or Longer, Fair Value	43,485	4,778
12 Months or Longer, Unrealized Losses	(1,054)	(374)
Total, Fair Value	76,332	44,335
Total, Unrealized Losses	(1,209)	(2,140)
Held-to-maturity securities, Less Than 12 Months, Fair Value		8,160
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses		(661)
Held-to-maturity securities, 12 Months or Longer, Fair Value		4,258
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses		(453)
Held-to-maturity securities, Total, Fair Value		12,418
Held-to-maturity securities, Total, Unrealized Losses		(1,114)
Private label mortgage-backed securities - residential
Less Than 12 Months, Fair Value	127	2,445
Less Than 12 Months, Unrealized Losses	(15)	(330)
12 Months or Longer, Fair Value	10,148	8,010
12 Months or Longer, Unrealized Losses	(1,155)	(992)
Total, Fair Value	10,275	10,455
Total, Unrealized Losses	(1,170)	(1,322)
Asset-backed securities
Less Than 12 Months, Fair Value	0	4,960
Less Than 12 Months, Unrealized Losses	0	(40)
12 Months or Longer, Fair Value	4,998	0
12 Months or Longer, Unrealized Losses	(2)	0
Total, Fair Value	4,998	4,960
Total, Unrealized Losses	(2)	(40)
Corporate securities
Less Than 12 Months, Fair Value	25,769	21,568
Less Than 12 Months, Unrealized Losses	(857)	(1,452)
12 Months or Longer, Fair Value	14,828	13,239
12 Months or Longer, Unrealized Losses	(2,173)	(1,265)
Total, Fair Value	40,597	34,807
Total, Unrealized Losses	(3,030)	(2,717)
Held-to-maturity securities, Less Than 12 Months, Fair Value		36,866
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses		(2,685)
Held-to-maturity securities, 12 Months or Longer, Fair Value		7,492
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses		(508)
Held-to-maturity securities, Total, Fair Value		44,358
Held-to-maturity securities, Total, Unrealized Losses		(3,193)
Mortgage-backed securities - residential
Less Than 12 Months, Fair Value	29,536	170,026
Less Than 12 Months, Unrealized Losses	(3,708)	(29,690)
12 Months or Longer, Fair Value	185,093	45,066
12 Months or Longer, Unrealized Losses	(29,342)	(7,284)
Total, Fair Value	214,629	215,092
Total, Unrealized Losses	(33,050)	(36,974)
Held-to-maturity securities, Less Than 12 Months, Fair Value		68,408
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses		(8,848)
Held-to-maturity securities, 12 Months or Longer, Fair Value		38,332
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses		(6,264)
Held-to-maturity securities, Total, Fair Value		106,740
Held-to-maturity securities, Total, Unrealized Losses		(15,112)
Agency mortgage-backed securities - commercial
Less Than 12 Months, Fair Value	0	10,560
Less Than 12 Months, Unrealized Losses	0	(926)
12 Months or Longer, Fair Value	15,530	5,280
12 Months or Longer, Unrealized Losses	(1,209)	(376)
Total, Fair Value	15,530	15,840
Total, Unrealized Losses	$ (1,209)	(1,302)
Held-to-maturity securities, Less Than 12 Months, Fair Value		4,552
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses		(1,266)
Held-to-maturity securities, 12 Months or Longer, Fair Value		0
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses		0
Held-to-maturity securities, Total, Fair Value		4,552
Held-to-maturity securities, Total, Unrealized Losses		$ (1,266)

Securities - HTM Portfolio Cred

Securities - HTM Portfolio Credit Rating (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	$ 211,097	$ 189,168
Standard & Poor's, AAA Rating | Moody's, Aaa Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	8,684
Standard & Poor's, AA+ Rating | Moody's, Aa1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	1,271
Standard & Poor's, AA Rating | Moody's, Aa2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	1,540
Standard & Poor's, A+ Rating | Moody's, A1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	1,794
Standard & Poor's, A Rating | Moody's, A2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	646
Standard & Poor's, A- Rating | Moody's, A3 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	9,517
Standard & Poor's, BBB+ Rating | Moody's, Baa1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	9,500
Standard & Poor's, BBB Rating | Moody's, Baa2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	11,000
Standard & Poor's, BBB- Rating | Moody's, Baa3 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	14,530
Standard & Poor's Not Rated | Moody's, Not Rated Agency
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	152,615
Municipal securities
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	13,935	$ 13,946
Municipal securities | Standard & Poor's, AAA Rating | Moody's, Aaa Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	8,684
Municipal securities | Standard & Poor's, AA+ Rating | Moody's, Aa1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	1,271
Municipal securities | Standard & Poor's, AA Rating | Moody's, Aa2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	1,540
Municipal securities | Standard & Poor's, A+ Rating | Moody's, A1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	1,794
Municipal securities | Standard & Poor's, A Rating | Moody's, A2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	646
Municipal securities | Standard & Poor's, A- Rating | Moody's, A3 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Municipal securities | Standard & Poor's, BBB+ Rating | Moody's, Baa1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Municipal securities | Standard & Poor's, BBB Rating | Moody's, Baa2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Municipal securities | Standard & Poor's, BBB- Rating | Moody's, Baa3 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Municipal securities | Standard & Poor's Not Rated | Moody's, Not Rated Agency
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Other
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	197,162
Other | Standard & Poor's, AAA Rating | Moody's, Aaa Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Other | Standard & Poor's, AA+ Rating | Moody's, Aa1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Other | Standard & Poor's, AA Rating | Moody's, Aa2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Other | Standard & Poor's, A+ Rating | Moody's, A1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Other | Standard & Poor's, A Rating | Moody's, A2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	0
Other | Standard & Poor's, A- Rating | Moody's, A3 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	9,517
Other | Standard & Poor's, BBB+ Rating | Moody's, Baa1 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	9,500
Other | Standard & Poor's, BBB Rating | Moody's, Baa2 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	11,000
Other | Standard & Poor's, BBB- Rating | Moody's, Baa3 Rating
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	14,530
Other | Standard & Poor's Not Rated | Moody's, Not Rated Agency
Debt Securities, Held-to-Maturity, Credit Quality Indicator [Line Items]
Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $192,463 and $168,483 in 2023 and 2022, respectively)	$ 152,615

Loans - Categories (Details)

Loans - Categories (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	$ 3,562,161	$ 3,452,607
Net deferred loan origination fees/costs and premiums/discounts on purchased loans and other	45,081	46,794
Allowance for credit losses	(36,879)	(31,737)	$ (28,251)	$ (27,841)
Net loans	3,570,363	3,467,664
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(1,437)	(1,711)	(1,979)	(1,891)
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(712)	(651)	(626)	(742)
Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(1,276)	(1,099)	(405)	(328)
Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(1,551)	(2,074)	(1,766)	(1,612)
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(10,273)	(10,519)	(9,971)	(10,385)
Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(1,570)	(1,753)	(1,783)	(1,776)
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(3,695)	(2,997)	(5,510)	(5,940)
Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(4,672)	(3,988)	(1,437)	(1,083)
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(2,340)	(2,168)	(1,435)	(1,387)
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(2,561)	(1,559)	(731)	(643)
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(254)	(69)	(65)	(64)
Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	(6,538)	(3,149)	(2,189)	(1,990)
Tax Refund Advance Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses			$ (354)	$ 0
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	2,805,806	2,719,349
Allowance for credit losses		(26,960)
Commercial Portfolio Segment | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	113,198	126,108
Allowance for credit losses		(1,711)
Commercial Portfolio Segment | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	59,643	61,836
Allowance for credit losses		(651)
Commercial Portfolio Segment | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	142,174	93,121
Allowance for credit losses		(1,099)
Commercial Portfolio Segment | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	158,147	181,966
Allowance for credit losses		(2,074)
Commercial Portfolio Segment | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	952,533	939,240
Allowance for credit losses		(10,519)
Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	604,898	621,032
Allowance for credit losses		(1,753)
Commercial Portfolio Segment | Public finance | Interest rate swaps
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	31,500	32,500
Commercial Portfolio Segment | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	256,670	272,461
Allowance for credit losses		(2,997)
Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	382,161	299,835
Allowance for credit losses		(3,988)
Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	136,382	123,750
Allowance for credit losses		(2,168)
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	756,355	733,258
Allowance for credit losses		(4,777)
Consumer Portfolio | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	392,062	383,948
Allowance for credit losses		(1,559)
Consumer Portfolio | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	26,160	24,712
Allowance for credit losses		(69)
Consumer Portfolio | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	$ 338,133	324,598
Allowance for credit losses		$ (3,149)

Loans - Provision for Credit Lo

Loans - Provision for Credit Losses on Off-Balance Sheet Commitments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2023	Jan. 01, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				$ 0
Provision for credit losses 1	$ 42
Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			$ 2,504	1,900
Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		$ 2,546	2,504
Commercial Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	47
Commercial Portfolio Segment | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			2,314
Commercial Portfolio Segment | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		2,361
Commercial Portfolio Segment | Commercial and industrial
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	39
Commercial Portfolio Segment | Commercial and industrial | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			110
Commercial Portfolio Segment | Commercial and industrial | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		149
Commercial Portfolio Segment | Owner-occupied commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	8
Commercial Portfolio Segment | Owner-occupied commercial real estate | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Owner-occupied commercial real estate | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		8
Commercial Portfolio Segment | Investor commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	39
Commercial Portfolio Segment | Investor commercial real estate | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			9
Commercial Portfolio Segment | Investor commercial real estate | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		48
Commercial Portfolio Segment | Construction
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	(39)
Commercial Portfolio Segment | Construction | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			2,193
Commercial Portfolio Segment | Construction | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		2,154
Commercial Portfolio Segment | Healthcare finance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	0
Commercial Portfolio Segment | Healthcare finance | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			2
Commercial Portfolio Segment | Healthcare finance | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		2
Consumer Portfolio
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	(5)
Consumer Portfolio | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			190
Consumer Portfolio | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		185
Consumer Portfolio | Residential mortgage
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	(14)
Consumer Portfolio | Residential mortgage | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			127
Consumer Portfolio | Residential mortgage | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		113
Consumer Portfolio | Home equity
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				0
Provision for credit losses 1	10
Consumer Portfolio | Home equity | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			52
Consumer Portfolio | Home equity | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		62
Consumer Portfolio | Other consumer loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures				$ 0
Provision for credit losses 1	$ (1)
Consumer Portfolio | Other consumer loans | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures			$ 11
Consumer Portfolio | Other consumer loans | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Line Items]
Liability for off-balance sheet credit exposures		$ 10

Loans - Recorded Investments in

Loans - Recorded Investments in Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Loans:
Ending balance: collectively evaluated for impairment		$ 3,427,463
Ending balance: individually evaluated for impairment		25,144
Total commercial and consumer loans	$ 3,562,161	3,452,607
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		30,983
Ending balance: individually evaluated for impairment		754
Total loans	36,879	31,737	$ 28,251	$ 27,841
Commercial and industrial
Loans:
Ending balance: collectively evaluated for impairment		116,307
Ending balance: individually evaluated for impairment		9,801
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		1,660
Ending balance: individually evaluated for impairment		51
Total loans	1,437	1,711	1,979	1,891
Owner-occupied commercial real estate
Loans:
Ending balance: collectively evaluated for impairment		60,266
Ending balance: individually evaluated for impairment		1,570
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		651
Ending balance: individually evaluated for impairment		0
Total loans	712	651	626	742
Investor commercial real estate
Loans:
Ending balance: collectively evaluated for impairment		93,121
Ending balance: individually evaluated for impairment		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		1,099
Ending balance: individually evaluated for impairment		0
Total loans	1,276	1,099	405	328
Construction
Loans:
Ending balance: collectively evaluated for impairment		181,966
Ending balance: individually evaluated for impairment		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		2,074
Ending balance: individually evaluated for impairment		0
Total loans	1,551	2,074	1,766	1,612
Single tenant lease financing
Loans:
Ending balance: collectively evaluated for impairment		939,240
Ending balance: individually evaluated for impairment		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		10,519
Ending balance: individually evaluated for impairment		0
Total loans	10,273	10,519	9,971	10,385
Public finance
Loans:
Ending balance: collectively evaluated for impairment		621,032
Ending balance: individually evaluated for impairment		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		1,753
Ending balance: individually evaluated for impairment		0
Total loans	1,570	1,753	1,783	1,776
Healthcare finance
Loans:
Ending balance: collectively evaluated for impairment		272,461
Ending balance: individually evaluated for impairment		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		2,997
Ending balance: individually evaluated for impairment		0
Total loans	3,695	2,997	5,510	5,940
Small business lending
Loans:
Ending balance: collectively evaluated for impairment		113,699
Ending balance: individually evaluated for impairment		10,051
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		1,465
Ending balance: individually evaluated for impairment		703
Total loans	2,340	2,168	1,435	1,387
Franchise finance
Loans:
Ending balance: collectively evaluated for impairment		299,835
Ending balance: individually evaluated for impairment		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		3,988
Ending balance: individually evaluated for impairment		0
Total loans	4,672	3,988	1,437	1,083
Residential mortgage
Loans:
Ending balance: collectively evaluated for impairment		380,272
Ending balance: individually evaluated for impairment		3,676
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		1,559
Ending balance: individually evaluated for impairment		0
Total loans	2,561	1,559	731	643
Home equity
Loans:
Ending balance: collectively evaluated for impairment		24,683
Ending balance: individually evaluated for impairment		29
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		69
Ending balance: individually evaluated for impairment		0
Total loans	254	69	65	64
Other consumer loans
Loans:
Ending balance: collectively evaluated for impairment		324,581
Ending balance: individually evaluated for impairment		17
Allowance for loan losses:
Ending balance: collectively evaluated for impairment		3,149
Ending balance: individually evaluated for impairment		0
Total loans	6,538	3,149	2,189	1,990
Tax Refund Advance Loans
Allowance for loan losses:
Total loans			$ 354	$ 0
Commercial Portfolio Segment
Loans:
Total commercial and consumer loans	2,805,806	2,719,349
Allowance for loan losses:
Total loans		26,960
Commercial Portfolio Segment | Commercial and industrial
Loans:
Total commercial and consumer loans	113,198	126,108
Allowance for loan losses:
Total loans		1,711
Commercial Portfolio Segment | Owner-occupied commercial real estate
Loans:
Total commercial and consumer loans	59,643	61,836
Allowance for loan losses:
Total loans		651
Commercial Portfolio Segment | Investor commercial real estate
Loans:
Total commercial and consumer loans	142,174	93,121
Allowance for loan losses:
Total loans		1,099
Commercial Portfolio Segment | Construction
Loans:
Total commercial and consumer loans	158,147	181,966
Allowance for loan losses:
Total loans		2,074
Commercial Portfolio Segment | Single tenant lease financing
Loans:
Total commercial and consumer loans	952,533	939,240
Allowance for loan losses:
Total loans		10,519
Commercial Portfolio Segment | Public finance
Loans:
Total commercial and consumer loans	604,898	621,032
Allowance for loan losses:
Total loans		1,753
Commercial Portfolio Segment | Healthcare finance
Loans:
Total commercial and consumer loans	256,670	272,461
Allowance for loan losses:
Total loans		2,997
Commercial Portfolio Segment | Small business lending
Loans:
Total commercial and consumer loans	136,382	123,750
Allowance for loan losses:
Total loans		2,168
Commercial Portfolio Segment | Franchise finance
Loans:
Total commercial and consumer loans	382,161	299,835
Allowance for loan losses:
Total loans		3,988
Consumer Portfolio
Loans:
Total commercial and consumer loans	756,355	733,258
Allowance for loan losses:
Total loans		4,777
Consumer Portfolio | Residential mortgage
Loans:
Total commercial and consumer loans	392,062	383,948
Allowance for loan losses:
Total loans		1,559
Consumer Portfolio | Home equity
Loans:
Total commercial and consumer loans	26,160	24,712
Allowance for loan losses:
Total loans		69
Consumer Portfolio | Other consumer loans
Loans:
Total commercial and consumer loans	$ 338,133	324,598
Allowance for loan losses:
Total loans		$ 3,149

Loans - Change in the Balances

Loans - Change in the Balances of the ALLL (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Allowance for loan losses:
Beginning balance	$ 31,737	$ 27,841
Provision for credit losses 1	9,373	791
Losses Charged Off	(7,257)	(1,731)
Recoveries	64	1,350
Ending balance	36,879	28,251
Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	2,962
Commercial and industrial
Allowance for loan losses:
Beginning balance	1,711	1,891
Provision for credit losses 1	6,810	88
Losses Charged Off	(6,965)	0
Recoveries	1	0
Ending balance	1,437	1,979
Commercial and industrial | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	(120)
Owner-occupied commercial real estate
Allowance for loan losses:
Beginning balance	651	742
Provision for credit losses 1	(1)	(116)
Losses Charged Off	0	0
Recoveries	0	0
Ending balance	712	626
Owner-occupied commercial real estate | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	62
Investor commercial real estate
Allowance for loan losses:
Beginning balance	1,099	328
Provision for credit losses 1	368	77
Losses Charged Off	0	0
Recoveries	0	0
Ending balance	1,276	405
Investor commercial real estate | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	(191)
Construction
Allowance for loan losses:
Beginning balance	2,074	1,612
Provision for credit losses 1	(88)	154
Losses Charged Off	0	0
Recoveries	0	0
Ending balance	1,551	1,766
Construction | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	(435)
Single tenant lease financing
Allowance for loan losses:
Beginning balance	10,519	10,385
Provision for credit losses 1	100	(1,645)
Losses Charged Off	0	0
Recoveries	0	1,231
Ending balance	10,273	9,971
Single tenant lease financing | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	(346)
Public finance
Allowance for loan losses:
Beginning balance	1,753	1,776
Provision for credit losses 1	(48)	7
Losses Charged Off	0	0
Recoveries	0	0
Ending balance	1,570	1,783
Public finance | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	(135)
Healthcare finance
Allowance for loan losses:
Beginning balance	2,997	5,940
Provision for credit losses 1	(336)	(430)
Losses Charged Off	0	0
Recoveries	0	0
Ending balance	3,695	5,510
Healthcare finance | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	1,034
Small business lending
Allowance for loan losses:
Beginning balance	2,168	1,387
Provision for credit losses 1	(105)	111
Losses Charged Off	(60)	(80)
Recoveries	3	17
Ending balance	2,340	1,435
Small business lending | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	334
Franchise finance
Allowance for loan losses:
Beginning balance	3,988	1,083
Provision for credit losses 1	997	354
Losses Charged Off	0	0
Recoveries	0	0
Ending balance	4,672	1,437
Franchise finance | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	(313)
Residential mortgage
Allowance for loan losses:
Beginning balance	1,559	643
Provision for credit losses 1	594	87
Losses Charged Off	0	0
Recoveries	2	1
Ending balance	2,561	731
Residential mortgage | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	406
Home equity
Allowance for loan losses:
Beginning balance	69	64
Provision for credit losses 1	51	(1)
Losses Charged Off	0	0
Recoveries	1	2
Ending balance	254	65
Home equity | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	133
Other consumer loans
Allowance for loan losses:
Beginning balance	3,149	1,990
Provision for credit losses 1	1,031	263
Losses Charged Off	(232)	(163)
Recoveries	57	99
Ending balance	6,538	2,189
Other consumer loans | Cumulative Effect, Period of Adoption, Adjustment
Allowance for loan losses:
Beginning balance	$ 2,533
Tax Refund Advance Loans
Allowance for loan losses:
Beginning balance		0
Provision for credit losses 1		1,842
Losses Charged Off		(1,488)
Recoveries		0
Ending balance		$ 354

Loans - Nonaccrual Loans (Detai

Loans - Nonaccrual Loans (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	$ 168,787
Fiscal year before current year	1,088,730
Two fiscal years before current year	466,224
Three fiscal years before current year	379,267
Four fiscal years before current year	390,435
More than five years before current year	1,033,074
Revolving loans amortized, cost basis	35,644
Revolving loans converted to term	0
Total loans	3,607,242		$ 3,499,401
Current fiscal year, writeoff	0
Fiscal Year before Current Fiscal Year, Writeoff	35
Two Years before Current Fiscal Year, Writeoff	6,921
Three Years before Current Fiscal Year, Writeoff	68
Four Years before Current Fiscal Year, Writeoff	158
More than Five Years before Current Fiscal Year, Writeoff	75
Revolving, Writeoff	0
Converted to Term Loan, Writeoff	0
Losses Charged Off	7,257	$ 1,731
Loans	3,562,161		3,452,607
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	6,965	0
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	60	80
Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	0	0
Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Losses Charged Off	232	$ 163
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			2,719,349
Loans	2,805,806		2,719,349
Commercial Portfolio Segment | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	2,393
Fiscal year before current year	33,645
Two fiscal years before current year	19,742
Three fiscal years before current year	2,648
Four fiscal years before current year	12,826
More than five years before current year	12,471
Revolving loans amortized, cost basis	29,473
Revolving loans converted to term	0
Total loans	113,198		126,108
Current fiscal year, writeoff	0
Fiscal Year before Current Fiscal Year, Writeoff	0
Two Years before Current Fiscal Year, Writeoff	6,914
Three Years before Current Fiscal Year, Writeoff	0
Four Years before Current Fiscal Year, Writeoff	51
More than Five Years before Current Fiscal Year, Writeoff	0
Revolving, Writeoff	0
Converted to Term Loan, Writeoff	0
Losses Charged Off	6,965
Loans	113,198		126,108
Commercial Portfolio Segment | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	411
Fiscal year before current year	11,447
Two fiscal years before current year	9,251
Three fiscal years before current year	15,316
Four fiscal years before current year	6,132
More than five years before current year	17,086
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	59,643		61,836
Loans	59,643		61,836
Commercial Portfolio Segment | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	4,878
Fiscal year before current year	40,758
Two fiscal years before current year	23,893
Three fiscal years before current year	10,049
Four fiscal years before current year	48,544
More than five years before current year	14,052
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	142,174		93,121
Loans	142,174		93,121
Commercial Portfolio Segment | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	785
Fiscal year before current year	80,984
Two fiscal years before current year	35,860
Three fiscal years before current year	38,905
Four fiscal years before current year	0
More than five years before current year	640
Revolving loans amortized, cost basis	973
Revolving loans converted to term	0
Total loans	158,147		181,966
Loans	158,147		181,966
Commercial Portfolio Segment | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	25,137
Fiscal year before current year	230,780
Two fiscal years before current year	98,253
Three fiscal years before current year	71,375
Four fiscal years before current year	147,335
More than five years before current year	379,653
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	952,533		939,240
Loans	952,533		939,240
Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	861
Fiscal year before current year	79,566
Two fiscal years before current year	31,950
Three fiscal years before current year	7,722
Four fiscal years before current year	48,759
More than five years before current year	436,040
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	604,898		621,032
Loans	604,898		621,032
Commercial Portfolio Segment | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	11,609
Three fiscal years before current year	143,651
Four fiscal years before current year	74,083
More than five years before current year	27,327
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			272,461
Loans	256,670		272,461
Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	19,718
Fiscal year before current year	51,093
Two fiscal years before current year	18,235
Three fiscal years before current year	20,153
Four fiscal years before current year	6,883
More than five years before current year	17,583
Revolving loans amortized, cost basis	2,717
Revolving loans converted to term	0
Total loans			123,750
Current fiscal year, writeoff	0
Fiscal Year before Current Fiscal Year, Writeoff	0
Two Years before Current Fiscal Year, Writeoff	0
Three Years before Current Fiscal Year, Writeoff	60
Four Years before Current Fiscal Year, Writeoff	0
More than Five Years before Current Fiscal Year, Writeoff	0
Revolving, Writeoff	0
Converted to Term Loan, Writeoff	0
Losses Charged Off	60
Loans	136,382		123,750
Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	78,796
Fiscal year before current year	237,658
Two fiscal years before current year	65,707
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			299,835
Loans	382,161		299,835
Commercial Portfolio Segment | Wealth Advisory Lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			0
Commercial Portfolio Segment | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			2,672,714
Commercial Portfolio Segment | Pass | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	2,393
Fiscal year before current year	33,609
Two fiscal years before current year	15,988
Three fiscal years before current year	2,648
Four fiscal years before current year	12,826
More than five years before current year	12,471
Revolving loans amortized, cost basis	29,091
Revolving loans converted to term	0
Total loans	109,026		114,934
Commercial Portfolio Segment | Pass | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	411
Fiscal year before current year	11,447
Two fiscal years before current year	9,251
Three fiscal years before current year	6,748
Four fiscal years before current year	6,132
More than five years before current year	14,753
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	48,742		50,721
Commercial Portfolio Segment | Pass | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	4,878
Fiscal year before current year	40,758
Two fiscal years before current year	23,893
Three fiscal years before current year	10,049
Four fiscal years before current year	48,544
More than five years before current year	6,169
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	134,291		93,121
Commercial Portfolio Segment | Pass | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	785
Fiscal year before current year	80,984
Two fiscal years before current year	34,384
Three fiscal years before current year	38,905
Four fiscal years before current year	0
More than five years before current year	640
Revolving loans amortized, cost basis	973
Revolving loans converted to term	0
Total loans	156,671		180,768
Commercial Portfolio Segment | Pass | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	25,137
Fiscal year before current year	230,780
Two fiscal years before current year	98,253
Three fiscal years before current year	71,375
Four fiscal years before current year	147,335
More than five years before current year	376,515
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	949,395		936,207
Commercial Portfolio Segment | Pass | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	861
Fiscal year before current year	79,566
Two fiscal years before current year	31,950
Three fiscal years before current year	7,722
Four fiscal years before current year	48,759
More than five years before current year	433,760
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	602,618		618,752
Commercial Portfolio Segment | Pass | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	11,609
Three fiscal years before current year	143,651
Four fiscal years before current year	72,756
More than five years before current year	27,327
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			271,085
Loans	255,343
Commercial Portfolio Segment | Pass | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	19,718
Fiscal year before current year	49,970
Two fiscal years before current year	17,396
Three fiscal years before current year	16,991
Four fiscal years before current year	5,369
More than five years before current year	14,320
Revolving loans amortized, cost basis	2,470
Revolving loans converted to term	0
Total loans			107,885
Loans	126,234
Commercial Portfolio Segment | Pass | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	78,796
Fiscal year before current year	237,658
Two fiscal years before current year	65,129
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			299,241
Loans	381,583
Commercial Portfolio Segment | Pass | Wealth Advisory Lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			0
Commercial Portfolio Segment | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			25,214
Commercial Portfolio Segment | Special Mention | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	36
Two fiscal years before current year	918
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	382
Revolving loans converted to term	0
Total loans	1,336		1,373
Commercial Portfolio Segment | Special Mention | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	8,568
Four fiscal years before current year	0
More than five years before current year	892
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	9,460		9,546
Commercial Portfolio Segment | Special Mention | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	7,883
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	7,883		0
Commercial Portfolio Segment | Special Mention | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	1,476
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	1,476		1,198
Commercial Portfolio Segment | Special Mention | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	3,138
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	3,138		3,033
Commercial Portfolio Segment | Special Mention | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	2,280
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	2,280		2,280
Commercial Portfolio Segment | Special Mention | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	1,327
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			1,376
Loans	1,327
Commercial Portfolio Segment | Special Mention | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	343
Two fiscal years before current year	123
Three fiscal years before current year	1,717
Four fiscal years before current year	714
More than five years before current year	2,078
Revolving loans amortized, cost basis	150
Revolving loans converted to term	0
Total loans			5,814
Loans	5,125
Commercial Portfolio Segment | Special Mention | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	578
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			594
Loans	578
Commercial Portfolio Segment | Special Mention | Wealth Advisory Lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			0
Commercial Portfolio Segment | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			21,421
Commercial Portfolio Segment | Substandard | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	2,836
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	2,836		9,801
Commercial Portfolio Segment | Substandard | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	1,441
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	1,441		1,569
Commercial Portfolio Segment | Substandard | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0		0
Commercial Portfolio Segment | Substandard | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0		0
Commercial Portfolio Segment | Substandard | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0		0
Commercial Portfolio Segment | Substandard | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0		0
Commercial Portfolio Segment | Substandard | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			0
Loans	0
Commercial Portfolio Segment | Substandard | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	780
Two fiscal years before current year	716
Three fiscal years before current year	1,445
Four fiscal years before current year	800
More than five years before current year	1,185
Revolving loans amortized, cost basis	97
Revolving loans converted to term	0
Total loans			10,051
Loans	5,023
Commercial Portfolio Segment | Substandard | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			0
Loans	0
Commercial Portfolio Segment | Substandard | Wealth Advisory Lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			0
Commercial Portfolio Segment | Doubtful | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0
Commercial Portfolio Segment | Doubtful | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0
Commercial Portfolio Segment | Doubtful | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0
Commercial Portfolio Segment | Doubtful | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0
Commercial Portfolio Segment | Doubtful | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0
Commercial Portfolio Segment | Doubtful | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans	0
Commercial Portfolio Segment | Doubtful | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	0
Commercial Portfolio Segment | Doubtful | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	0
Commercial Portfolio Segment | Doubtful | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	0
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			733,258
Loans	756,355		733,258
Consumer Portfolio | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	4,207
Fiscal year before current year	191,819
Two fiscal years before current year	98,095
Three fiscal years before current year	34,388
Four fiscal years before current year	12,303
More than five years before current year	51,250
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Total loans			383,948
Loans	392,062		383,948
Consumer Portfolio | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	2,463
Fiscal year before current year	10,080
Two fiscal years before current year	3,903
Three fiscal years before current year	3,518
Four fiscal years before current year	780
More than five years before current year	3,709
Revolving loans amortized, cost basis	1,707
Revolving loans converted to term	0
Total loans			24,712
Loans	26,160		24,712
Consumer Portfolio | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	29,138
Fiscal year before current year	120,900
Two fiscal years before current year	49,726
Three fiscal years before current year	31,542
Four fiscal years before current year	32,790
More than five years before current year	73,263
Revolving loans amortized, cost basis	774
Revolving loans converted to term	0
Total loans			324,598
Current fiscal year, writeoff	0
Fiscal Year before Current Fiscal Year, Writeoff	35
Two Years before Current Fiscal Year, Writeoff	7
Three Years before Current Fiscal Year, Writeoff	8
Four Years before Current Fiscal Year, Writeoff	107
More than Five Years before Current Fiscal Year, Writeoff	75
Revolving, Writeoff	0
Converted to Term Loan, Writeoff	0
Losses Charged Off	232
Loans	338,133		324,598
Consumer Portfolio | Performing | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	4,207
Fiscal year before current year	191,584
Two fiscal years before current year	98,095
Three fiscal years before current year	34,312
Four fiscal years before current year	12,303
More than five years before current year	50,555
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	391,056
Consumer Portfolio | Performing | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	2,463
Fiscal year before current year	10,080
Two fiscal years before current year	3,903
Three fiscal years before current year	3,518
Four fiscal years before current year	780
More than five years before current year	3,709
Revolving loans amortized, cost basis	1,707
Revolving loans converted to term	0
Loans	26,160
Consumer Portfolio | Performing | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	29,138
Fiscal year before current year	120,846
Two fiscal years before current year	49,726
Three fiscal years before current year	31,542
Four fiscal years before current year	32,736
More than five years before current year	73,230
Revolving loans amortized, cost basis	774
Revolving loans converted to term	0
Loans	337,992
Consumer Portfolio | Nonaccrual | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	235
Two fiscal years before current year	0
Three fiscal years before current year	76
Four fiscal years before current year	0
More than five years before current year	695
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	1,006
Consumer Portfolio | Nonaccrual | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	0
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	0
More than five years before current year	0
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	0
Consumer Portfolio | Nonaccrual | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current year	0
Fiscal year before current year	54
Two fiscal years before current year	0
Three fiscal years before current year	0
Four fiscal years before current year	54
More than five years before current year	33
Revolving loans amortized, cost basis	0
Revolving loans converted to term	0
Loans	$ 141
Consumer Portfolio | Nonaccrual
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			1,065
Consumer Portfolio | Nonaccrual | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			1,048
Consumer Portfolio | Nonaccrual | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			0
Consumer Portfolio | Nonaccrual | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			17
Consumer Portfolio | Performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			732,193
Consumer Portfolio | Performing | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			382,900
Consumer Portfolio | Performing | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			24,712
Consumer Portfolio | Performing | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans			$ 324,581

Loans - Loan Portfolio Aging (D

Loans - Loan Portfolio Aging (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	$ 3,562,161	$ 3,452,607
30-59 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	434	542
60-89 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	1,698	1,491
90 Days or More Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	2,624	3,721
Financial Asset, Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	4,756	5,754
Financial Asset, Not Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	3,557,405	3,446,853
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	2,805,806	2,719,349
Commercial Portfolio Segment | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	113,198	126,108
Commercial Portfolio Segment | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	59,643	61,836
Commercial Portfolio Segment | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	142,174	93,121
Commercial Portfolio Segment | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	158,147	181,966
Commercial Portfolio Segment | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	952,533	939,240
Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	604,898	621,032
Commercial Portfolio Segment | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	256,670	272,461
Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	136,382	123,750
Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	382,161	299,835
Commercial Portfolio Segment | 30-59 Days Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	81
Commercial Portfolio Segment | 30-59 Days Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	55	57
Commercial Portfolio Segment | 30-59 Days Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	313
Commercial Portfolio Segment | 60-89 Days Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	1,198
Commercial Portfolio Segment | 60-89 Days Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	1,426	0
Commercial Portfolio Segment | 60-89 Days Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	51
Commercial Portfolio Segment | 90 Days or More Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	2,354	3,485
Commercial Portfolio Segment | 90 Days or More Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	132
Commercial Portfolio Segment | Financial Asset, Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	1,198
Commercial Portfolio Segment | Financial Asset, Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	3,835	3,542
Commercial Portfolio Segment | Financial Asset, Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	313
Commercial Portfolio Segment | Financial Asset, Not Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	113,198	125,976
Commercial Portfolio Segment | Financial Asset, Not Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	59,643	61,836
Commercial Portfolio Segment | Financial Asset, Not Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	142,174	93,121
Commercial Portfolio Segment | Financial Asset, Not Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	158,147	180,768
Commercial Portfolio Segment | Financial Asset, Not Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	952,533	939,240
Commercial Portfolio Segment | Financial Asset, Not Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	604,898	621,032
Commercial Portfolio Segment | Financial Asset, Not Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	256,670	272,461
Commercial Portfolio Segment | Financial Asset, Not Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	132,547	120,208
Commercial Portfolio Segment | Financial Asset, Not Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	382,161	299,522
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	756,355	733,258
Consumer Portfolio | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	392,062	383,948
Consumer Portfolio | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	26,160	24,712
Consumer Portfolio | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	338,133	324,598
Consumer Portfolio | 30-59 Days Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	301	0
Consumer Portfolio | 30-59 Days Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Consumer Portfolio | 30-59 Days Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	78	91
Consumer Portfolio | 60-89 Days Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	234	283
Consumer Portfolio | 60-89 Days Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Consumer Portfolio | 60-89 Days Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	38	10
Consumer Portfolio | 90 Days or More Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	235	185
Consumer Portfolio | 90 Days or More Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Consumer Portfolio | 90 Days or More Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	35	0
Consumer Portfolio | Financial Asset, Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	770	468
Consumer Portfolio | Financial Asset, Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	0	0
Consumer Portfolio | Financial Asset, Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	151	101
Consumer Portfolio | Financial Asset, Not Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	391,292	383,480
Consumer Portfolio | Financial Asset, Not Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	26,160	24,712
Consumer Portfolio | Financial Asset, Not Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial and consumer loans	$ 337,982	$ 324,497

Loans - Internal Credit Assessm

Loans - Internal Credit Assessment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccural, interest income	$ 25
Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans		$ 9,221	$ 7,450
Total Loans 90 Days or More Past Due and Accruing		0	0
Nonaccrual Loans with no Allowance for Credit Losses		7,778	5,401
Commercial Portfolio Segment | Commercial and industrial | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans		2,836	51
Total Loans 90 Days or More Past Due and Accruing		0	0
Nonaccrual Loans with no Allowance for Credit Losses		2,836	0
Commercial Portfolio Segment | Owner-occupied commercial real estate | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans		1,441	1,570
Total Loans 90 Days or More Past Due and Accruing		0	0
Nonaccrual Loans with no Allowance for Credit Losses		1,441	1,570
Commercial Portfolio Segment | Small business lending | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans		3,797	4,764
Total Loans 90 Days or More Past Due and Accruing		0	0
Nonaccrual Loans with no Allowance for Credit Losses		2,354	2,766
Consumer Portfolio | Residential mortgage | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans		1,006	1,048
Total Loans 90 Days or More Past Due and Accruing		0	79
Nonaccrual Loans with no Allowance for Credit Losses		1,006	1,048
Consumer Portfolio | Other consumer loans | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans		141	17
Total Loans 90 Days or More Past Due and Accruing		0	0
Nonaccrual Loans with no Allowance for Credit Losses		$ 141	$ 17

Loans - Impaired Loans (Details

Loans - Impaired Loans (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) loan	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			$ 23,226
Loans without a specific valuation allowance - Unpaid Principal Balance			24,134
Loans without a specific valuation allowance			0
Impaired loans, recorded investment			1,918
Loans with a specific valuation allowance - Unpaid Principal Balance			1,918
Loans without a specific valuation allowance - Average Balance		$ 7,434
Loans without a specific valuation allowance - Interest Income		8
Loans with a specific valuation allowance - Average Balance		3,972
Loans with a specific valuation allowance - Interest Income		17
Average recorded investment		11,406
Interest Income		25
Other real estate owned	$ 106		0
Mortgage loans in process of foreclosure, number of loans | loan	2
Mortgage loans in process of foreclosure, amount	$ 400		100
Total loans	36,879	28,251	31,737	$ 27,841
Loans with a specific valuation allowance			754
Specific allowance			754
Recorded investment			25,144
Unpaid principal balance			26,052
Financing receivable, troubled debt restructuring		700
Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	2,147
Residential Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	1,401
Other Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	5,295
Collateral Pledged
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	8,843
Total loans	603
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			9,750
Loans without a specific valuation allowance - Unpaid Principal Balance			9,750
Loans without a specific valuation allowance			0
Impaired loans, recorded investment			51
Loans with a specific valuation allowance - Unpaid Principal Balance			51
Loans with a specific valuation allowance - Average Balance		627
Loans with a specific valuation allowance - Interest Income		0
Total loans	1,437	1,979	1,711	1,891
Loans with a specific valuation allowance			51
Commercial and industrial | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Commercial and industrial | Residential Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Commercial and industrial | Other Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	2,836
Commercial and industrial | Collateral Pledged
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	2,836
Total loans	0
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			1,570
Loans without a specific valuation allowance - Unpaid Principal Balance			1,779
Loans without a specific valuation allowance			0
Loans without a specific valuation allowance - Average Balance		3,307
Loans without a specific valuation allowance - Interest Income		0
Total loans	712	626	651	742
Owner-occupied commercial real estate | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Owner-occupied commercial real estate | Residential Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Owner-occupied commercial real estate | Other Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	1,441
Owner-occupied commercial real estate | Collateral Pledged
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	1,441
Total loans	0
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans with a specific valuation allowance - Average Balance		1,094
Loans with a specific valuation allowance - Interest Income		0
Total loans	10,273	9,971	10,519	10,385
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans with a specific valuation allowance - Average Balance		918
Loans with a specific valuation allowance - Interest Income		17
Total loans	3,695	5,510	2,997	5,940
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			8,184
Loans without a specific valuation allowance - Unpaid Principal Balance			8,705
Loans without a specific valuation allowance			0
Impaired loans, recorded investment			1,867
Loans with a specific valuation allowance - Unpaid Principal Balance			1,867
Loans without a specific valuation allowance - Average Balance		830
Loans without a specific valuation allowance - Interest Income	0
Loans with a specific valuation allowance - Average Balance		1,333
Loans with a specific valuation allowance - Interest Income		0
Total loans	2,340	1,435	2,168	1,387
Loans with a specific valuation allowance			703
Small business lending | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	2,147
Small business lending | Residential Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	395
Small business lending | Other Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	877
Small business lending | Collateral Pledged
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	3,419
Total loans	603
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			3,676
Loans without a specific valuation allowance - Unpaid Principal Balance			3,835
Loans without a specific valuation allowance			0
Loans without a specific valuation allowance - Average Balance		3,273
Loans without a specific valuation allowance - Interest Income		8
Total loans	2,561	731	1,559	643
Residential mortgage | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Residential mortgage | Residential Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	1,006
Residential mortgage | Other Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Residential mortgage | Collateral Pledged
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	1,006
Total loans	0
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			29
Loans without a specific valuation allowance - Unpaid Principal Balance			29
Loans without a specific valuation allowance			0
Loans without a specific valuation allowance - Average Balance		14
Loans without a specific valuation allowance - Interest Income		0
Total loans	254	65	69	64
Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance			17
Loans without a specific valuation allowance - Unpaid Principal Balance			36
Loans without a specific valuation allowance			0
Loans without a specific valuation allowance - Average Balance		10
Loans without a specific valuation allowance - Interest Income		0
Total loans	6,538	$ 2,189	$ 3,149	$ 1,990
Other consumer loans | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Other consumer loans | Residential Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	0
Other consumer loans | Other Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	141
Other consumer loans | Collateral Pledged
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual Loans	141
Total loans	$ 0

Premises and Equipment - Summar

Premises and Equipment - Summary (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (11,881)	$ (10,897)
Premises and equipment, net	74,248	72,711
Land
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	5,598	5,598
Right of use leased asset
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	160	206
Construction in process
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	177	714
Building and improvements
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	60,199	57,505
Furniture and equipment
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	$ 19,995	$ 19,585

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,687	$ 4,687

Servicing Asset (Details)

Servicing Asset (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Servicing Asset at Fair Value, Amount [Roll Forward]
Balance, beginning of period	$ 6,255	$ 4,702
Originated and purchased servicing	1,112	844
Paydowns:	(339)	(256)
Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model	284	(41)
Loan servicing asset revaluation	(55)	(297)
Balance, end of period	$ 7,312	$ 5,249

Servicing Asset - Unpaid princi

Servicing Asset - Unpaid principal balance (Details) - Loan servicing - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 356,808	$ 318,194
SBA guaranteed loans
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 356,808	$ 318,194

Servicing Asset - Narrative (De

Servicing Asset - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Servicing Assets at Fair Value [Line Items]
Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model	$ (284)	$ 41
Loan servicing
Servicing Assets at Fair Value [Line Items]
Loan servicing revenue	785	585
Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model	$ 100	$ 300

Subordinated Debt (Details Text

Subordinated Debt (Details Textual) - Subordinated Debt - USD ($)	1 Months Ended
	Aug. 31, 2021	Oct. 31, 2020	Jun. 30, 2019	Dec. 30, 2021	Dec. 31, 2019
2031 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount					$ 37,000,000
Fixed annual interest rate (as a percent)					6%
2030 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount		$ 10,000,000
Fixed annual interest rate (as a percent)		6%
2031 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount	$ 60,000,000
Fixed annual interest rate (as a percent)	3.75%
Unregistered 2031 Notes
Debt Instrument [Line Items]
Debt Instrument, Principal Amount Exchanged				$ 59,300,000
Debt Instrument, Principal Amount Remaining				$ 700,000
LIBOR | 2031 Notes
Debt Instrument [Line Items]
Basis spread on variable rate			4.11%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | 2030 Notes
Debt Instrument [Line Items]
Basis spread on variable rate		5.795%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | 2031 Notes
Debt Instrument [Line Items]
Basis spread on variable rate	3.11%

Subordinated Debt - Schedule of

Subordinated Debt - Schedule of Subordinated Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Principal	$ 614,929	$ 614,928
Unamortized Debt Issuance Costs	(2,392)	(2,468)
Subordinated Debt
Debt Instrument [Line Items]
Principal	107,000	107,000
Unamortized Debt Issuance Costs	(2,392)	(2,468)
Subordinated Debt | 2029 Notes
Debt Instrument [Line Items]
Principal	37,000	37,000
Unamortized Debt Issuance Costs	(981)	(1,020)
Subordinated Debt | 2030 Notes
Debt Instrument [Line Items]
Principal	10,000	10,000
Unamortized Debt Issuance Costs	(178)	(184)
Subordinated Debt | 2031 Notes
Debt Instrument [Line Items]
Principal	60,000	60,000
Unamortized Debt Issuance Costs	$ (1,233)	$ (1,264)

Benefit Plans - Activity (Detai

Benefit Plans - Activity (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Restricted Stock Awards
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	0
Cancelled/Forfeited (in dollars per share) | $ / shares	$ 0
Cancelled/Forfeited (in shares) | shares	0
Vested (in shares) | shares	0
Balance at end of period (in shares) | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	0
Vested (in dollars per share) | $ / shares	0
Balance at end of period (in dollars per share) | $ / shares	$ 0
Restricted Stock Awards | Plan 2022
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	3,558
Granted (in shares) | shares	0
Balance at end of period (in shares) | shares	3,558
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 36.84
Granted (in dollars per share) | $ / shares	0
Balance at end of period (in dollars per share) | $ / shares	$ 36.84
Deferred Stock Units
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	0
Cancelled/Forfeited (in dollars per share) | $ / shares	$ 0
Cancelled/Forfeited (in shares) | shares	0
Vested (in shares) | shares	0
Balance at end of period (in shares) | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	0
Vested (in dollars per share) | $ / shares	0
Balance at end of period (in dollars per share) | $ / shares	$ 0
Deferred Stock Units | Plan 2022
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	0
Balance at end of period (in shares) | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	0
Balance at end of period (in dollars per share) | $ / shares	$ 0
Restricted Stock Units
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	101,734
Granted (in shares) | shares	0
Cancelled/Forfeited (in dollars per share) | $ / shares	$ 27.56
Cancelled/Forfeited (in shares) | shares	(278)
Vested (in shares) | shares	(35,808)
Balance at end of period (in shares) | shares	65,648
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 35.93
Granted (in dollars per share) | $ / shares	0
Vested (in dollars per share) | $ / shares	31.87
Balance at end of period (in dollars per share) | $ / shares	$ 38.18
Restricted Stock Units | Plan 2022
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	71,660
Balance at end of period (in shares) | shares	71,660
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	24.75
Balance at end of period (in dollars per share) | $ / shares	$ 24.75

Benefit Plans - Deferred Stock

Benefit Plans - Deferred Stock Rights (Details)	3 Months Ended
	Mar. 31, 2023 shares
Deferred Stock Rights
Outstanding, beginning of period (in shares)	40,414,000
Granted (in shares)	100,000
Outstanding, end of period (in shares)	40,514,000

Benefit Plans (Details Textual)

Benefit Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	May 16, 2022
Allocated share-based compensation expense	$ 372	$ 640
Compensation cost not yet recognized	$ 1,200
Period for recognition	1 year 7 months 6 days
Percentage of annual retainer received in either common stock or deferred stock rights	100%
Plan 2013
Number of shares authorized (in shares)	750,000
Plan 2022
Number of shares authorized (in shares)			400,000
Share-based Payment Arrangement, Expense	$ 100
Director
Common stock shares reserved for future grants (in shares)	180,000
Plan 2022 | Restricted Stock Units
Compensation cost not yet recognized	$ 1,700
Period for recognition	2 years 9 months 18 days
Voting and Nonvoting Common Stock | Voting and Nonvoting Common Stock
Allocated share-based compensation expense	$ 372	$ 640

Commitments and Credit Risk (De

Commitments and Credit Risk (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Other Commitments [Line Items]
Loan commitments	$ 501.7	$ 485.4
Capital Addition Purchase Commitments
Other Commitments [Line Items]
Other contract commitment	$ 67.2

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Total available-for-sale securities	$ 395,833	$ 390,384
Loans held-for-sale (mandatory pricing agreements)	2,209	9,110
Servicing asset	7,312	6,255
Derivative, fair value	(22)	0
Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	2,209	9,110
Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Servicing asset	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	0	0
Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	395,833	390,384
Servicing asset	0	0
Significant Other Observable Inputs (Level 2) | Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	2,209	9,110
Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Servicing asset	7,312	6,255
Significant Unobservable Inputs (Level 3) | Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	0	0
U.S. Government-sponsored agencies
Total available-for-sale securities	37,047	33,809
U.S. Government-sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
U.S. Government-sponsored agencies | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	37,047	33,809
U.S. Government-sponsored agencies | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Municipal securities
Total available-for-sale securities	68,636	67,276
Municipal securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Municipal securities | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	68,636	67,276
Municipal securities | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Agency mortgage-backed securities - residential 1
Total available-for-sale securities	216,752	215,092
Agency mortgage-backed securities - residential 1 | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Agency mortgage-backed securities - residential 1 | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities		215,092
Agency mortgage-backed securities - residential 1 | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Private label mortgage-backed securities - residential
Total available-for-sale securities	10,275	10,455
Private label mortgage-backed securities - residential | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Private label mortgage-backed securities - residential | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Asset-backed securities
Total available-for-sale securities	4,998	4,960
Asset-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Asset-backed securities | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	4,998	4,960
Asset-backed securities | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Corporate securities
Total available-for-sale securities	42,595	42,952
Corporate securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Corporate securities | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	42,595	42,952
Corporate securities | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
IRLCs
Derivative, fair value	0	133
IRLCs | Quoted Prices in Active Markets for Identical Assets (Level 1)
Derivative, fair value	0	0
IRLCs | Significant Other Observable Inputs (Level 2)
Derivative, fair value	0	0
IRLCs | Significant Unobservable Inputs (Level 3)
Derivative, fair value	0	133
Agency mortgage-backed securities - commercial
Total available-for-sale securities	15,530	15,840
Agency mortgage-backed securities - commercial | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Agency mortgage-backed securities - commercial | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	15,530	15,840
Agency mortgage-backed securities - commercial | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Interest rate swaps | Interest rate swaps
Derivative liability, fair value	6,089	8,645
Interest rate swaps | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swaps
Derivative liability, fair value	0	0
Interest rate swaps | Significant Other Observable Inputs (Level 2) | Interest rate swaps
Derivative liability, fair value	6,089	8,645
Interest rate swaps | Significant Unobservable Inputs (Level 3) | Interest rate swaps
Derivative liability, fair value	0	0
Forward contracts | Forward contracts
Derivative, fair value	(22)	97
Forward contracts | Quoted Prices in Active Markets for Identical Assets (Level 1) | Forward contracts
Derivative, fair value	(22)	97
Forward contracts | Significant Other Observable Inputs (Level 2) | Forward contracts
Derivative, fair value	0	0
Forward contracts | Significant Unobservable Inputs (Level 3) | Forward contracts
Derivative, fair value	0	0
Derivatives designated as hedging instruments | Interest rate swaps
Derivative, fair value	$ 1,707	$ 2,093

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Fair Value Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Interest Rate Lock Commitments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 133	$ 718
Additions:	0	0
Paydowns	0	0
Included in net income	(133)	(806)
Ending balance	0	(88)
Servicing asset
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	6,255	4,702
Additions:	1,112	844
Paydowns	(339)	(256)
Included in net income	284	(41)
Ending balance	$ 7,312	$ 5,249

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Quantitative Information About Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Impaired loans, recorded investment		$ 1,918
Servicing asset	$ 7,312	6,255
Quoted Prices in Active Markets for Identical Assets (Level 1)
Servicing asset	0	0
Significant Other Observable Inputs (Level 2)
Servicing asset	0	0
Significant Unobservable Inputs (Level 3)
Servicing asset	7,312	6,255
IRLCs | Significant Unobservable Inputs (Level 3)
IRLCs Fair Value		133
Servicing asset | Significant Unobservable Inputs (Level 3)
Servicing asset	7,312	6,255
Impaired Loans | Significant Unobservable Inputs (Level 3)
Impaired loans, recorded investment	$ 3,676	$ 1,164
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Minimum
IRLC - Loan closing rates		31%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Maximum
IRLC - Loan closing rates		100%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
IRLC - Loan closing rates		89%
Measurement Input, Prepayment Rate [Member] | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Minimum
Servicing asset, discount rate	0%	0%
Measurement Input, Prepayment Rate [Member] | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Maximum
Servicing asset, discount rate	25%	25%
Measurement Input, Prepayment Rate [Member] | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
Servicing asset, discount rate	11.50%	14.60%
Measurement Input, Discount Rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3)
Servicing asset, discount rate	14%	14%
Measurement Input, Discount Rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
Servicing asset, discount rate	14%	14%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Minimum
Impaired loans, measurement input	4%	0%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Maximum
Impaired loans, measurement input	25%	25%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
Impaired loans, measurement input	12%	20%

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Cash and cash equivalents, Carrying Amount	$ 303,972	$ 256,552
Securities held-to-maturity, net, Carrying Amount	210,761	189,168
Held-to-maturity, at fair value	192,463	168,483
Loans Held-For-Sale	15,935	12,401
Loans held for sale, Fair Value	2,209	9,110
Accrued interest receivable, Carrying Amount	22,322	21,069
FHLB stock, Carrying Amount	28,350	28,350
Deposits, Carrying Amount	3,622,290	3,441,245
FHLB Advances, Carrying Amount	614,929	614,928
Accrued interest payable	2,592	2,913
Subordinated debt, Carrying Value	104,608	104,532
Reported Value Measurement
Cash and cash equivalents, Carrying Amount	303,972	256,552
Securities held-to-maturity, net, Carrying Amount		189,168
Loans receivable	3,570,363	3,467,664
Accrued interest receivable, Carrying Amount	22,322	21,069
FHLB stock, Carrying Amount	28,350	28,350
Deposits, Carrying Amount	3,622,290	3,441,245
Fair Value
Cash and cash equivalents, Fair Value	303,972	256,552
Held-to-maturity, at fair value	192,463	168,483
Loans held for sale, Fair Value	15,935	12,401
Loans receivable, fair value	3,378,228	3,225,845
Accrued interest receivable, Fair Value	22,322	21,069
FHLB stock, Fair Value	28,350	28,350
Deposits, Fair Value	3,589,180	3,415,390
FHLB Advances, Fair Value	601,563	596,455
Subordinated debt, Fair Value	101,550	102,669
Accrued interest payable, Fair Value	2,592	2,913
Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)
Cash and cash equivalents, Fair Value	303,972	256,552
Held-to-maturity, at fair value	0	0
Loans held for sale, Fair Value	0	0
Loans receivable, fair value	0	0
Accrued interest receivable, Fair Value	22,322	21,069
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,778,865	1,974,344
FHLB Advances, Fair Value	0	0
Subordinated debt, Fair Value	31,450	32,560
Accrued interest payable, Fair Value	2,592	2,913
Fair Value | Significant Other Observable Inputs (Level 2)
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity, at fair value	192,463	168,483
Loans held for sale, Fair Value	15,935	12,401
Loans receivable, fair value	0	0
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	28,350	28,350
Deposits, Fair Value	0	0
FHLB Advances, Fair Value	601,563	596,455
Subordinated debt, Fair Value	70,100	70,109
Accrued interest payable, Fair Value	0	0
Fair Value | Significant Unobservable Inputs (Level 3)
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity, at fair value	0	0
Loans held for sale, Fair Value	0	0
Loans receivable, fair value	3,378,228	3,225,845
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,810,315	1,441,046
FHLB Advances, Fair Value	0	0
Subordinated debt, Fair Value	0	0
Accrued interest payable, Fair Value	$ 0	$ 0

Mortgage Banking Activities (De

Mortgage Banking Activities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Principal Transaction Revenue [Line Items]
Loans originated for sale	$ 36,300	$ 152,400
Proceeds from sale of loans	43,500	162,400
Mortgage banking activities
Principal Transaction Revenue [Line Items]
Gain on loans sold	464	2,062
Loss resulting from the change in fair value of loans held-for-sale	(136)	(489)
(Loss) gain resulting from the change in fair value of derivatives	(252)	300
Net revenue from mortgage banking activities	$ 76	$ 1,873

Derivative Financial Instrume_3

Derivative Financial Instruments - Carrying Amount and Adjustment (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		12 Months Ended
	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost			$ 436,520		$ 436,183
Payments for swap termination payments		$ 46,100
Cash pledged as collateral			6,600			$ 7,700
Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the hedged assets			69,243		68,963
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets			(1,707)		$ (2,088)
Amortized cost			50,000
Securities available-for-sale | Derivatives designated as hedging instruments | Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Payments for swap termination payments	$ 1,900
Amortization Expense			100
Loans | Derivatives designated as hedging instruments | Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortization Expense			$ 1,000	$ 1,000

Derivative Financial Instrume_4

Derivative Financial Instruments - Interest Swap Derivatives (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended	12 Months Ended
	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 1,750			$ 0
Fair Value			(22)			0
Interest expense			32,459	$ 10,284
Payments for swap termination payments		$ 46,100
Cash pledged as collateral			6,600				$ 7,700
Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fair value hedging adjustment			(1,707)			(2,088)
Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 50,000			50,000
Weighted Average Remaining Maturity (years)			1 year 7 months 6 days		1 year 9 months 18 days
Fair Value			$ 1,707			$ 2,093
Weighted-Average Rate			2.33%			2.33%
Loans | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Weighted Average Remaining Maturity (years)			11 years 1 month 6 days
Securities available-for-sale | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 50,000			$ 50,000
Weighted Average Remaining Maturity (years)			1 year 7 months 6 days		1 year 9 months 18 days
Fair Value			$ 1,707			$ 2,093
Weighted-Average Rate			2.33%			2.33%
Payments for swap termination payments	$ 1,900
3-month LIBOR | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 110,000			$ 110,000
Weighted Average Remaining Maturity (years)			3 years 9 months 18 days		4 years 1 month 6 days
Fair Value			$ 3,126			$ 4,787
Derivative, variable interest rate			2.88%			2.88%
1-month LIBOR | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 60,000			$ 60,000
Weighted Average Remaining Maturity (years)			4 months 24 days		7 months 6 days
Fair Value			$ 473			$ 735
Derivative, variable interest rate			2.88%			2.88%
Fed Funds Effective | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 40,000			$ 40,000
Weighted Average Remaining Maturity (years)			1 year 2 months 12 days		1 year 4 months 24 days
Fair Value			$ 783			$ 1,030
Derivative, variable interest rate			2.78%			2.78%

Derivative Financial Instrume_5

Derivative Financial Instruments - Notional Amounts and Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Asset Derivatives
Notional Amount	$ 260,000	$ 291,862
Fair Value	6,089	8,875
Derivative Liability [Abstract]
Notional Amount	1,750	0
Derivative, fair value	(22)	0
Interest Rate Lock Commitments
Derivative Liability [Abstract]
Derivative, fair value	0	133
Derivatives designated as hedging instruments | Interest rate swaps
Derivative Liability [Abstract]
Notional Amount	50,000	50,000
Derivative, fair value	1,707	2,093
Derivatives not designated as hedging instruments | Interest Rate Lock Commitments
Asset Derivatives
Notional Amount	0	14,862
Fair Value	0	133
Derivatives not designated as hedging instruments | Forward contracts
Asset Derivatives
Notional Amount	0	17,000
Fair Value	0	97
Derivatives not designated as hedging instruments | Forward contracts
Derivative Liability [Abstract]
Notional Amount	1,750	0
Fair Value	(22)	0
Loans | Derivatives designated as hedging instruments | Interest rate swaps
Asset Derivatives
Notional Amount	50,000	50,000
Fair Value	1,707	2,093
Securities available-for-sale | Derivatives designated as hedging instruments | Interest rate swaps
Asset Derivatives
Notional Amount	210,000	210,000
Fair Value	4,382	6,552
Derivative Liability [Abstract]
Notional Amount	50,000	50,000
Derivative, fair value	$ 1,707	$ 2,093

Derivative Financial Instrume_6

Derivative Financial Instruments - Gain (Loss) Recognized (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Asset Derivatives | Interest Rate Lock Commitments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	$ 0	$ 0
Asset Derivatives | Forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	0	1,102
Forward contracts | Liability Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	(119)	0
Interest Rate Lock Commitments | Liability Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	$ (133)	$ (802)

Derivative Financial Instrume_7

Derivative Financial Instruments - Effect Of Derivatives on Income (Details) - Interest rate swaps - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Other Comprehensive Income	$ (2,170)	$ 9,334
Securities - taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	0
Gain (loss) recognized on the condensed consolidated statements of income		0
Securities - non-taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	294
Gain (loss) recognized on the condensed consolidated statements of income		(260)
Total interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	294
Gain (loss) recognized on the condensed consolidated statements of income		(260)
Deposits
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(418)
Gain (loss) recognized on the condensed consolidated statements of income		670
Other borrowed funds
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(522)
Gain (loss) recognized on the condensed consolidated statements of income		696
Total interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(940)
Gain (loss) recognized on the condensed consolidated statements of income		1,366
Net interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	$ 1,234
Gain (loss) recognized on the condensed consolidated statements of income		$ (1,626)

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	$ 364,974	$ 380,338
Net change in unrealized gain	2,942	(13,949)
Reclassification of net loss realized and included in earnings	158	119
Other comprehensive gain (loss) before tax	3,100	(13,830)
Income tax provision (benefit)	717	(2,008)
Other comprehensive income (loss) - net of tax	2,383	(11,822)
Balance, end of period	355,572	374,655
Reclassifications from accumulated other comprehensive loss to earnings before tax	(158)	(119)
Tax benefit	(46)	(27)
Total reclassifications from accumulated other comprehensive loss	(112)	(92)
Available-For-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(35,831)	(2,555)
Net change in unrealized gain	5,112	(17,881)
Reclassification of net loss realized and included in earnings	0	0
Other comprehensive gain (loss) before tax	5,112	(17,881)
Income tax provision (benefit)	1,170	(4,077)
Other comprehensive income (loss) - net of tax	3,942	(13,804)
Balance, end of period	(31,889)	(16,359)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	5,714	(8,484)
Net change in unrealized gain	(2,170)	9,334
Reclassification of net loss realized and included in earnings	0	0
Other comprehensive gain (loss) before tax	(2,170)	9,334
Income tax provision (benefit)	(499)	3,318
Other comprehensive income (loss) - net of tax	(1,671)	6,016
Balance, end of period	4,043	(2,468)
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(33,636)	(11,039)
Other comprehensive income (loss) - net of tax	2,383	(11,822)
Balance, end of period	(31,253)	(22,861)
AOCI, Accumulated Gain (Loss), Debt Securities, Held-To-Maturity, Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(3,519)	0
Net change in unrealized gain	0	(5,402)
Reclassification of net loss realized and included in earnings	158	119
Other comprehensive gain (loss) before tax	158	(5,283)
Income tax provision (benefit)	46	(1,249)
Other comprehensive income (loss) - net of tax	112	(4,034)
Balance, end of period	$ (3,407)	$ (4,034)

Recent Accounting Pronounceme_4

Recent Accounting Pronouncements - Adjustments for ASC 326 Adoption (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jan. 01, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	$ 36,879		$ 31,737	$ 28,251	$ 27,841
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Held-to-maturity, debt securities, allowance for credit loss	336
Commercial and industrial
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	1,437		1,711	1,979	1,891
Owner-occupied commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	712		651	626	742
Investor commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	1,276		1,099	405	328
Construction
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	1,551		2,074	1,766	1,612
Single tenant lease financing
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	10,273		10,519	9,971	10,385
Public finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	1,570		1,753	1,783	1,776
Healthcare finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	3,695		2,997	5,510	5,940
Small business lending
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	2,340		2,168	1,435	1,387
Franchise finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	4,672		3,988	1,437	1,083
Residential mortgage
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	2,561		1,559	731	643
Home equity
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	254		69	65	64
Other consumer loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans	6,538		3,149	$ 2,189	$ 1,990
Commercial Portfolio Segment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			26,960
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Commercial and industrial
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			1,711
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Owner-occupied commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			651
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Investor commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			1,099
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Construction
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			2,074
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Single tenant lease financing
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			10,519
Commercial Portfolio Segment | Public finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			1,753
Commercial Portfolio Segment | Healthcare finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			2,997
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Commercial Portfolio Segment | Small business lending
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			2,168
Commercial Portfolio Segment | Franchise finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			3,988
Consumer Portfolio
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			4,777
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Consumer Portfolio | Residential mortgage
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			1,559
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Consumer Portfolio | Home equity
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			69
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Consumer Portfolio | Other consumer loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			3,149
Liabilities [Abstract]
Liability for off-balance sheet credit exposures			0
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		$ 2,962	2,962
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		2,504	1,900
Held-to-maturity, debt securities, allowance for credit loss			300
Cumulative Effect, Period of Adoption, Adjustment | Commercial and industrial
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			(120)
Cumulative Effect, Period of Adoption, Adjustment | Owner-occupied commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			62
Cumulative Effect, Period of Adoption, Adjustment | Investor commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			(191)
Cumulative Effect, Period of Adoption, Adjustment | Construction
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			(435)
Cumulative Effect, Period of Adoption, Adjustment | Single tenant lease financing
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			(346)
Cumulative Effect, Period of Adoption, Adjustment | Public finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			(135)
Cumulative Effect, Period of Adoption, Adjustment | Healthcare finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			1,034
Cumulative Effect, Period of Adoption, Adjustment | Small business lending
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			334
Cumulative Effect, Period of Adoption, Adjustment | Franchise finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			(313)
Cumulative Effect, Period of Adoption, Adjustment | Residential mortgage
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			406
Cumulative Effect, Period of Adoption, Adjustment | Home equity
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			133
Cumulative Effect, Period of Adoption, Adjustment | Other consumer loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans			$ 2,533
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(110)
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		2,314
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Commercial and industrial
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(120)
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		110
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Owner-occupied commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		62
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		0
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Investor commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(191)
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		9
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Construction
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(435)
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		2,193
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Single tenant lease financing
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(346)
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Public finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(135)
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Healthcare finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		1,034
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		2
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Small business lending
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		334
Cumulative Effect, Period of Adoption, Adjustment | Commercial Portfolio Segment | Franchise finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		(313)
Cumulative Effect, Period of Adoption, Adjustment | Consumer Portfolio
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		3,072
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		190
Cumulative Effect, Period of Adoption, Adjustment | Consumer Portfolio | Residential mortgage
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		406
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		127
Cumulative Effect, Period of Adoption, Adjustment | Consumer Portfolio | Home equity
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		133
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		52
Cumulative Effect, Period of Adoption, Adjustment | Consumer Portfolio | Other consumer loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		2,533
Liabilities [Abstract]
Liability for off-balance sheet credit exposures		11
Cumulative Effect, Period of Adoption, Adjusted Balance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		34,699
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	2,546	2,504
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		26,850
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	2,361
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Commercial and industrial
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		1,591
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	149
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Owner-occupied commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		713
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	8
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Investor commercial real estate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		908
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	48
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Construction
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		1,639
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	2,154
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Single tenant lease financing
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		10,173
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Public finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		1,618
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Healthcare finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		4,031
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	2
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Small business lending
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		2,502
Cumulative Effect, Period of Adoption, Adjusted Balance | Commercial Portfolio Segment | Franchise finance
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		3,675
Cumulative Effect, Period of Adoption, Adjusted Balance | Consumer Portfolio
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		7,849
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	185
Cumulative Effect, Period of Adoption, Adjusted Balance | Consumer Portfolio | Residential mortgage
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		1,965
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	113
Cumulative Effect, Period of Adoption, Adjusted Balance | Consumer Portfolio | Home equity
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		202
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	62
Cumulative Effect, Period of Adoption, Adjusted Balance | Consumer Portfolio | Other consumer loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total loans		$ 5,682
Liabilities [Abstract]
Liability for off-balance sheet credit exposures	$ 10